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A B S T R A C T
Background
According to international guidelines and literature, all patients with intermittent claudication should receive an initial treatment of
cardiovascular risk modification, lifestyle coaching, and supervised exercise therapy. In the literature, supervised exercise therapy oJen
consists of treadmill or track walking. However, alternative modes of exercise therapy have been described and yielded similar results
to walking. This raises the following question: which exercise mode produces the most favourable results? This is the first update of the
original review published in 2014.
Objectives
To assess the eMects of alternative modes of supervised exercise therapy compared to traditional walking exercise in patients with
intermittent claudication.
Search methods
The Cochrane Vascular Information Specialist searched the Cochrane Vascular Specialised Register, CENTRAL, MEDLINE, Embase and
CINAHL databases and World Health Organization International Clinical Trials Registry Platform and ClinicalTrials.gov trials registers to 4
March 2019. We also undertook reference checking, citation searching and contact with study authors to identify additional studies. No
language restriction was applied.
Selection criteria
We included parallel-group randomised controlled trials comparing alternative modes of exercise training or combinations of exercise
modes with a control group of supervised walking exercise in patients with clinically determined intermittent claudication. The supervised
walking programme needed to be supervised at least twice a week for a consecutive six weeks of training.
Data collection and analysis
Two review authors independently selected studies, extracted data, and assessed the risk of bias for each study. As we included studies
with diMerent treadmill test protocols and diMerent measuring units (metres, minutes, or seconds), the standardised mean diMerence (SMD)
approach was used for summary statistics of mean walking distance (MWD) and pain-free walking distance (PFWD). Summary estimates
were obtained for all outcome measures using a random-eMects model. We used the GRADE approach to assess the certainty of the
evidence.
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Main results
For this update, five additional studies were included, making a total of 10 studies that randomised a total of 527 participants with
intermittent claudication (IC). The alternative modes of exercise therapy included cycling, lower-extremity resistance training, upper-arm
ergometry, Nordic walking, and combinations of exercise modes. Besides randomised controlled trials, two quasi-randomised trials were
included. Overall risk of bias in included studies varied from high to low. According to GRADE criteria, the certainty of the evidence was
downgraded to low, due to the relatively small sample sizes, clinical inconsistency, and inclusion of three studies with risk of bias concerns.
Overall, comparing alternative exercise modes versus walking showed no clear diMerences for MWD at 12 weeks (standardised mean
diMerence (SMD) -0.01, 95% confidence interval (CI) -0.29 to 0.27; P = 0.95; 6 studies; 274 participants; low-certainty evidence); or at the
end of training (SMD -0.11, 95% CI -0.33 to 0.11; P = 0.32; 9 studies; 412 participants; low-certainty evidence). Similarly, no clear diMerences
were detected in PFWD at 12 weeks (SMD -0.01, 95% CI -0.26 to 0.25; P = 0.97; 5 studies; 249 participants; low-certainty evidence); or at
the end of training (SMD -0.06, 95% CI -0.30 to 0.17; P = 0.59; 8 studies, 382 participants; low-certainty evidence). Four studies reported on
health-related quality of life (HR-QoL) and three studies reported on functional impairment. As the studies used diMerent measurements,
meta-analysis was only possible for the walking impairment questionnaire (WIQ) distance score, which demonstrated little or no diMerence
between groups (MD -5.52, 95% CI -17.41 to 6.36; P = 0.36; 2 studies; 96 participants; low-certainty evidence).
Authors' conclusions
This review found no clear diMerence between alternative exercise modes and supervised walking exercise in improving the maximum
and pain-free walking distance in patients with intermittent claudication. The certainty of this evidence was judged to be low, due to
clinical inconsistency, small sample size and risk of bias concerns. The findings of this review indicate that alternative exercise modes
may be useful when supervised walking exercise is not an option. More RCTs with adequate methodological quality and suMicient power
are needed to provide solid evidence for comparisons between each alternative exercise mode and the current standard of supervised
treadmill walking. Future RCTs should investigate outcome measures on walking behaviour, physical activity, cardiovascular risk, and HR-
QoL, using standardised testing methods and reporting of outcomes to allow meaningful comparison across studies.
P L A I N   L A N G U A G E   S U M M A R Y
How e6ective are supervised exercise programmes compared to supervised walking programmes for treating intermittent
claudication?
Why this question is important
Intermittent claudication is the medical term for pain in the lower leg (or both legs) that develops during exercise (for example, walking)
and usually goes away aJer a few minutes’ rest. This pain is produced by a restriction of blood flow to the leg muscles. This restriction
in blood flow is caused by the partial blockage of arteries (vessels that deliver oxygen-rich blood around the body) by a build-up of fatty
deposits (atherosclerosis). This results in a reduced oxygen supply reaching the leg muscles.
International guidelines recommend that people with intermittent claudication should exercise by walking (for example, on a treadmill)
while supervised by a physical or exercise therapist. The goal of these exercises is to increase the distance people can walk, and to limit
the impact of intermittent claudication on their quality of life.
Supervised walking programmes are not the only type of supervised exercise available. There are other options, such as strength training,
Nordic walking (walking with specially designed poles to exercise the upper as well as the lower body) or cycling. To find out how eMective
other types of supervised exercise programmes are compared to supervised walking programmes, we reviewed the evidence from research
studies.
How we identified and assessed the evidence
First, we searched for all relevant studies in the medical literature. We then compared the results, and summarised the evidence from all
the studies. Finally, we assessed how certain the evidence was. We considered factors such as the way studies were conducted, study sizes,
and consistency of findings across studies. Based on our assessments, we categorised the evidence as being of very low, low, moderate
or high certainty.
What we found
We found ten studies on a total of 527 people with intermittent claudication. The studies compared supervised walking programmes
against:
* exercises to strengthen the leg muscles (four studies);
* Nordic walking (three studies);
* cycling (one study);
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* arm ergometry (pedalling with the arms on an exercise machine – one study);
* a combination of diMerent types of exercise (four studies).
The programmes lasted between six and 24 weeks.
The evidence suggests that there may be little to no diMerence between supervised walking and other types of supervised exercise in terms
of:
* the average maximum distance that people can walk aJer 12 weeks of exercise, or once they have completed the exercise programme;
* the average distance that people can walk without feeling pain aJer 12 weeks of exercise, or once they have completed the exercise
programme; or
* disability (aJer 12 to 24 weeks of exercise).
We do not know if there is a diMerence in quality of life, since the studies that investigated this used diMerent measurement tools to assess
it, and we could not compare the results.
What this means
This review suggests that supervised walking and other types of supervised exercise programmes may have similar eMects on how far
people with intermittent claudication can walk, and how far they can walk without pain. However, our confidence in this finding is limited,
mainly because:
* the studies we reviewed were small;
* the types of supervised walking exercises that were evaluated varied across studies; and
* concerns about how some studies were conducted.
Future studies that use robust methods and include large numbers of people are needed to provide stronger evidence for comparing
diMerent types of supervised exercise programmes for intermittent claudication.
How-up-to date is this review?
The evidence in this Cochrane Review is current to March 2019.
Modes of exercise training for intermittent claudication (Review)







































































S U M M A R Y   O F   F I N D I N G S
 
Summary of findings 1.   Alternative modes of exercise compared to walking exercise for people with intermittent claudication
Alternative modes of exercise compared to walking exercise in people with intermittent claudication (IC)
Patient or population: patients with IC
Setting: hospital or community-based (supervised exercise therapy)




























- SMD 0.01 lower






LOW 1 2 3
This translates to no clear difference in MWD after 12 weeks
of training when comparing alternative modes of exercise
with walking exercise.
Maximum walking distance
(at end of training, ranging from 6
to 24 weeks)
- SMD 0.11 lower






LOW 1 2 3
This translates to no clear difference in MWD at the end of




- SMD 0.01 lower






LOW 1 2 3
This translates to no clear difference in PFWD after 12 weeks
of training when comparing alternative modes of exercise
with walking exercise.
Pain-free walking distance
(at end of training, ranging from 6
to 24 weeks)
- SMD 0.06 lower






LOW 1 2 3
This translates to no clear difference in PFWD at the end of
training when comparing alternative modes of exercise with
walking exercise.
Health-related QoL
(at end of training, ranging from
12 to 24 weeks)
- - - - - Four studies reported HR-QoL using different outcome mea-
surements so meaningful comparison was not possible.
Self-reported functional im-
pairment (WIQ)
  MD 5.52 lower






LOW 1 3 4
This translates to little or no important difference in the WIQ


































































































































(at end of training, ranging from
12 to 24 weeks)
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: confidence interval; IC: intermittent claudication; HR-QoL; health related quality of life; MD: mean difference; MWD: maximum walking distance; PFWD: pain-free walk-
ing distance; QoL: quality of life; SMD: standardised mean difference; WIQ: Walking Impairment Questionnaire
GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect
1 The certainty of evidence was downgraded one level, because of evidence of clinical inconsistency, as studies used diMerent alternative modes of exercise in the control groups.
2 The certainty of evidence was downgraded one level, because this analysis included 3 studies with risk of bias concerns.
3 The possibility of publication bias could not be ruled out, yet we did not consider it suMicient to downgrade the certainty of the evidence.
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B A C K G R O U N D
This review includes a glossary of abbreviations and definitions
(Table 1).
Description of the condition
Peripheral arterial disease (PAD) is a chronic arterial occlusive
disease caused by progressive atherosclerosis. Several arterial
segments can be aMected, such as the aorta and iliac, femoral,
popliteal, and tibial arteries in the limbs. Approximately 202 million
people are aMected with PAD of the lower extremities, defined as
an ankle-brachial index below 0.90 in either leg (Fowkes 2013). The
incidence of PAD increases with age, in particular aJer the age of
40 years. In high-income countries, PAD aMects 5.41% of men and
5.28% of women at the age of 45 to 49 years. This prevalence rises
to 18.83% in men and 18.38% in women at the age of 85 to 89
years (Fowkes 2013). The most common symptom is intermittent
claudication (IC), defined as a cramping pain in the muscles of the
leg(s) that occurs during exercise and is relieved by a short period
of rest. Because of this symptom, patients have a reduced pain-
free and maximum walking capacity, which restricts the patients'
activity and mobility, leading to diminished health-related quality
of life (Dumville 2004; McDermott 2001).
Moreover, given that PAD is a systemic disease which is
characterised by generalised atherosclerosis, individuals with IC
have an increased total risk of cardiovascular events beyond the
claudication symptoms. Patients with IC have a five-year all-cause
mortality rate of 10% to 15% and a 20% chance of a non-fatal
cardiovascular event (Aboyans 2018). When IC progresses to critical
limb ischaemia, an even higher mortality rate of 25% aJer one year
is found (Conte 2015).
Description of the intervention
All patients with IC should receive a multicomponent
therapy consisting of cardiovascular risk management, lifestyle
counselling, and exercise therapy to reduce the associated
serious health risks (Aboyans 2018; Gerhard-Herman 2017).
Several randomised controlled trials and systematic reviews have
compared walking exercise supervised by a physical or exercise
therapist to non-supervised exercise, usual care, placebo, single
walking advice, endovascular interventions, or bypass surgery
(Fakhry 2018; Hageman 2018; Lane 2017; Parmenter 2015). The
current evidence supports supervised exercise therapy as the
primary treatment to improve walking capacity and health-related
quality of life in patients with IC. Furthermore, community-based
supervised exercise appears to be at least as eMicacious as
programmes provided in a hospital setting (Bendermacher 2007;
Kruidenier 2009; Nicolaï 2010). Less attention has been paid to
the mode of (supervised) exercise. Besides traditional walking,
alternative modes of supervised exercise training, such as cycling,
upper-extremity cycle ergometer exercise, Nordic walking, and
strength training exist and are associated with a significantly
improved walking capacity (Golledge 2018; Parmenter 2011;
Tompra 2015). Notably, this update includes Nordic walking as
an alternative exercise mode, in contrast to the original review in
which Nordic walking was considered a diMerent walking protocol
(Lauret 2014). Recent research has provided new insights on the
potential benefits of Nordic walking. This core-focused walking
technique substantially diMers from traditional walking, as it
engages the muscles of the arms and trunk to reduce the load on
the legs during walking (Golledge 2018).
Exercise training oJen provokes the claudication symptoms,
depending on the protocol used (pain-free walking or walking until
maximum pain). This can be considered as an adverse event, which
is particularly relevant to patients in the context of expectation
management. It generally takes several weeks for the patient
to experience improvement and this type of treatment requires
perseverance from the patient. Research has demonstrated that
supervised exercise therapy is safe and has an exceedingly low all-
cause complication rate (Gommans 2015).
How the intervention might work
Physical activity, which includes exercise, is associated with
many health benefits (Piercy 2018). In patients with IC, exercise
therapy significantly reduces symptoms and improves health-
related quality of life. The exact mechanism for these benefits
remains unclear and is probably multifactorial. A number of
potential mechanisms have been suggested, such as induction
of vascular angiogenesis, metabolic adaptations within skeletal
muscle, improved endothelial flow-mediated dilatation, reduced
inflammatory activation, reduced endothelial and mitochondrial
dysfunction, improved walking eMiciency, and increased pain
tolerance (Conte 2015; Haas 2012; Harwood 2016). Additionally,
supervised exercise therapy potentially reduces cardiovascular risk
(Jansen 2019).
If walking ability is severely compromised by IC symptoms,
traditional walking exercise may not provide suMicient stimulus
to improve aerobic capacity. In those patients, alternative modes
of aerobic exercise might be more beneficial than traditional
walking. An example is Nordic walking, which is a core-focused
walking technique which reduces the load on the legs during
walking (Golledge 2018). Cycling is also a non-weight-bearing
mode of exercise; and muscle strength seems to be associated
with improved walking ability, which might explain the potential
benefits of progressive resistance training of the lower limbs
(Parmenter 2013b).
Why it is important to do this review
In most studies, supervised exercise programmes involve treadmill
or track walking that is of suMicient intensity to provoke
claudication symptoms. Walking exercise is alternated with rest
over the course of a 30- to 60-minute session. Unfortunately, not
all patients with IC are able to complete the exercise protocol
because of concomitant comorbidity, such as arthrosis, chronic
obstructive pulmonary disease, stroke, or cardiac complaints. For
these patients, an adjusted protocol or alternative exercise regimen
may be proposed. Being able to oMer several modes of exercise
might improve therapy adherence, as this enables better alignment
with personal preferences. Combinations of aerobic and muscle-
strengthening activities might be preferable, as these provide the
most extensive health benefits according to the Physical Activity
Guidelines (Piercy 2018).
This systematic review aims to determine the eMect of alternative
exercise modes on walking distance and health-related quality of
life in patients with IC, compared to traditional walking exercise.
Other Cochrane systematic reviews have demonstrated favourable
results for supervised exercise programmes compared to usual care
Modes of exercise training for intermittent claudication (Review)
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and non-supervised programmes (Hageman 2018; Lane 2017). We
solely compared diMerent exercise modalities between supervised
programmes.
This is the first update of the original review published in 2014
(Lauret 2014). The original review concluded that there was no clear
diMerence between supervised walking exercise and alternative
exercise modes in improving the maximum and pain-free walking
distance, but also highlighted the need for more studies with larger
sample sizes. The international guidelines for the management of
IC recommend considering the use of alternative exercise modes
(such as cycling, upper-arm ergometry and strength training) to
improve walking ability and functional status when walking is not
an option for patients (Aboyans 2018; Gerhard-Herman 2017). In
this update, we have presented all the currently available evidence
on alternative exercise modes to help patients and healthcare
providers determine which may oMer the most benefit to them.
O B J E C T I V E S
To assess the eMects of alternative modes of supervised exercise
therapy compared to traditional walking exercise in patients with
intermittent claudication.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included parallel-group randomised controlled trials (RCTs)
comparing (combinations of) alternative modes of exercise training
(for example, ergometry, strength training, aerobic exercise, Nordic
walking, etc.) with traditional walking exercise in patients with
intermittent claudication (IC). Quasi-randomised trials were also
included, but were distinguished from properly randomised trials
in 'Risk of bias' assessment. We excluded cross-over, factorial, or
cluster-RCTs.
Types of participants
We included studies where the study participants consisted
of adults (18 years and older) with clinically determined IC
(Fontaine II or Rutherford 1 to 3 (Aboyans 2018)), who were
considered for conservative treatment. We excluded studies
of participants with asymptomatic lower-limb atherosclerosis
identified by testing. When studies described a mixture of
asymptomatic and symptomatic participants, we contacted the
authors to ask if a subanalysis was available. If not, we excluded
these studies.
Types of interventions
We included all RCTs comparing alternative modes of exercise
training (e.g. arm ergometry, strength training, cycling, Nordic
walking, etc.) or combinations of exercise modes with a control
group of traditional walking exercise. All exercise programmes had
to be supervised at least twice a week during six consecutive weeks
of training. We excluded studies reporting an exercise programme
with a duration of less than six weeks of training or with less than
two supervised sessions a week.
We excluded all types of mechanical intermittent compression
treatments as we did not consider them to be exercise training.
We excluded studies comparing diMerent settings of walking
exercise (supervised versus unsupervised, community versus
hospital-based) or comparisons of diMerent walking protocols (low-
versus high-frequency training, low- versus high-intensity training,
diMerent treadmill exercise protocols).
Types of outcome measures
Studies were included only if reported outcome measures were
available at baseline and aJer at least six weeks of follow-up.
Primary outcomes
• Maximal treadmill walking distance or time (MWD/T)
Secondary outcomes
• Pain-free treadmill walking distance or time (PFWD/T)
• Health-related quality of life scores (HR-QoL)
• Self-reported functional impairment (Walking Impairment
Questionnaire)
Search methods for identification of studies
Electronic searches
The Cochrane Vascular Information Specialist conducted
systematic searches of the following databases for randomised
controlled trials and controlled clinical trials without language,
publication year or publication status restrictions:
• Cochrane Vascular Specialised Register via the Cochrane
Register of Studies (CRS-Web searched on 4 March 2019);
• Cochrane Central Register of Controlled Trials (CENTRAL)
Cochrane Register of Studies Online (CRSO 2019, issue 2);
• MEDLINE (Ovid MEDLINE® Epub Ahead of Print, In-Process &
Other Non-Indexed Citations, Ovid MEDLINE® Daily and Ovid
MEDLINE®) (searched from 1 January 2013 to 4 March 2019);
• Embase Ovid (searched from 1 January 2013 to 4 March 2019);
• CINAHL Ebsco (searched from 1 January 2017 to 4 March 2019);
• AMED Ovid (searched from 1 January 2017 to 4 March 2019).
The Information Specialist modelled search strategies for other
databases on the search strategy designed for CENTRAL. Where
appropriate, they were combined with adaptations of the highly
sensitive search strategy designed by the Cochrane Collaboration
for identifying randomised controlled trials and controlled clinical
trials (as described in the Cochrane Handbook for Systematic
Reviews of Interventions Chapter 6, Lefebvre 2011). Search
strategies for major databases are provided in Appendix 1.
The Information Specialist searched the following trials registries
on 4 March 2019:




We searched the reference lists of relevant studies identified by the
above search strategies to identify other relevant citations.
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Data collection and analysis
Selection of studies
Two review authors (SJ and UA) independently selected studies
for this review. Three review authors (GJ, HF, and JT) confirmed
the suitability of selected studies for inclusion. Any disagreements
regarding inclusion/exclusion of selected studies were solved
through discussion.
Data extraction and management
Two review authors (SJ and UA) independently extracted data using
a standard data collection form and entered data into Review
Manager (Review Manager 2020). When necessary, additional
information from included studies was sought by contacting study
authors. The extracted study data consisted of the following:
• study characteristics, including study design, method of
randomisation, exclusions post-randomisation, publication
year, country, and study period;
• baseline characteristics, including number of participants,
losses to follow-up, mean age, gender distribution, and
inclusion and exclusion criteria;
• type of interventions, including mode(s) of exercise, duration
of programme, number of sessions, number of supervised
sessions, and exercise protocol; and
• mean maximum walking distance or time, mean pain-free
walking distance or time, mean quality of life scores at baseline
and follow-up periods, and functional impairment information.
Assessment of risk of bias in included studies
Two review authors (SJ and UA) assessed the risk of bias for each
study according to the checklist of design components, which
comprised sequence generation, allocation concealment, blinding
of personnel and participants, blinding of outcome assessments,
incomplete outcome data, selective reporting, and other forms of
bias. Another review author (GJ) confirmed the methodological
quality of studies, primarily for adequacy of allocation concealment
and follow-up. Due to the intervention (exercise), blinding of
participants and personnel was not possible. Although this could
introduce bias, we decided to consider the risk of bias to be
low, since all studies experienced the same limitation. Consensus
was achieved through informal discussion. The adequacy of each
category was summarised as having 'low', 'unclear', or 'high'
risk, according to criteria provided in the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2019).
Measures of treatment e6ect
We assessed treatment eMects on the MWD and PFWD aJer 12
weeks follow-up and at the end of training. As studies with
diMerent treadmill test protocols and diMerent measuring units
(metres, minutes, or seconds) were included, the standardised
mean diMerence (SMD) with 95% confidence intervals (CI) approach
was used for summary statistics of MWD and PFWD. The SMDs were
interpreted by using rules of thumb for eMect sizes, in which a SMD
of 0.2 represents a small eMect, 0.5 a moderate eMect, and 0.8 a
large eMect (Cohen 1988). For HR-QoL and functional impairment
scores, data were only pooled if more than one study used the same
questionnaire. Therefore, the summary statistic was expressed as
mean diMerence (MD) with 95% CI.
Unit of analysis issues
We used the individual participant as the unit of analysis. Studies
using cross-over design were not included in this review.
Dealing with missing data
Where applicable, missing data were requested from the authors.
We expected that most studies reported baseline and final values
with the corresponding standard deviations (SD). Where only
change scores were provided, final value means were calculated
using change score means and baseline data. Standard deviations
were imputed using a conservative correlation coeMicient of 0.5 for
within-patient correlation from baseline to follow-up according to
instructions in the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2019).
Assessment of heterogeneity
Statistical heterogeneity was assessed by the Chi2-test (P < 0.10
considered as heterogeneous) and the I2 statistic (I2 > 50%
considered as moderate to substantial risk of heterogeneity),
in order to assess whether observed variation in trial results
was compatible with the variation expected by chance alone
(Higgins 2019). A rough guide to help interpretation of the I2
statistic is as follows: 0% to 40%: might not be important;
30% to 60%: may represent moderate heterogeneity; 50% to
90%: may represent substantial heterogeneity; and 75% to 100%:
considerable heterogeneity.
Assessment of reporting biases
No language restrictions were applied, to prevent language bias.
In case of suMicient studies (≥ 10 studies), we planned to assess
publication bias with a funnel plot (Higgins 2019). If bias was
present (demonstrated by an asymmetrical appearance of the
funnel plot), the eMect calculated by the meta-analysis would tend
to overestimate the intervention eMect.
Data synthesis
Data were analysed using Review Manager soJware (Review
Manager 2020). We used final values, SDs, and number of
participants to enable calculation of the SMD. The SDs were used to
standardise the mean diMerences to a single scale and to compute
study weights. It was assumed that between-study variation in
SDs reflected only diMerences in measurement scales and not
diMerences in the reliability of outcome measures or variability
among study populations. As the alternative modes of exercise
included in the current review consisted of several diMerent types
of exercise, we could not assume that intervention eMects across
studies were identical. Therefore, the DerSimonian and Laird
random-eMects model was used to analyse treatment eMect, to
account for between-study variance (DerSimonian 1986). The data
of each study were summarised in forest plots and summary
estimates with a 95% CI were calculated. A two-sided P (with a value
≤ 0.05) was considered statistically significant.
Subgroup analysis and investigation of heterogeneity
Treatment eMects were based on the outcomes aJer 12 weeks
follow-up and at the end of training, in order to deal with
heterogeneity in follow-up duration and because international
guidelines recommend a programme duration of 12 weeks.
Furthermore, we performed subgroup analyses of each type of
alternative exercise mode and combinations of exercise modes,
Modes of exercise training for intermittent claudication (Review)
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if more than one trial comparing the specific exercise mode or
combinations of exercise to traditional walking was available.
Sensitivity analysis
We examined individual study eMects by removing each study one
at a time to check whether excluding a particular study significantly
changed the results. In addition, we planned to perform sensitivity
analyses on the methodological quality of the studies. Studies with
apparent risk of bias were removed to examine whether excluding
these studies significantly changed the results. Studies with more
than one domain at high risk or more than three domains at unclear
risk were considered to be at high risk of bias.
Summary of findings and the assessment of certainty of the
evidence
We created a 'Summary of findings' table using GRADE-proGDT
soJware (GRADEproGDT 2015) to present the main review findings
for 'Alternative modes of exercise compared to walking exercise
in people with intermittent claudication' (Summary of findings 1).
We included the outcomes listed in Types of outcome measures.
These were MWD, PFWD, HRQoL and functional impairment. The
system developed by the Grades of Recommendation, Assessment,
Development and Evaluation Working Group (GRADE working
group) was used for grading the certainty of the evidence as
high, moderate, low and very low, based on within-study risk of
bias, directness of evidence, heterogeneity, precision of eMects
estimates, and risk of publication bias (Atkins 2004).
R E S U L T S
Description of studies
See: Characteristics of included studies; Characteristics of excluded
studies; Characteristics of ongoing studies.
Results of the search
See Figure 1.
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Figure 1.   Study flow diagram
 
Modes of exercise training for intermittent claudication (Review)









Cochrane Database of Systematic Reviews
For this update, the updated electronic searches identified 6777
new records (aJer removal of duplicates), of which four new
studies were included in the review (Bulinska 2016; Delaney 2015;
Kropielnicka 2018; Szymczak 2016). We also re-evaluated the 2708
records identified in the first review published in 2014, according
to the updated inclusion criteria (inclusion of Nordic walking as
an alternative mode of exercise). This resulted in the inclusion
of one additional study (Collins 2012). Two new ongoing studies
were identified (ACTRN12616000243415; NCT03837639); and six
new studies were excluded (Delaney 2014; EXERT Study 2018; Kao
2012; Oakley 2008; Parmenter 2013; Van Schaardenburgh 2017).
Included studies
For this update, five additional studies were included (Bulinska
2016; Collins 2012; Delaney 2015; Kropielnicka 2018; Szymczak
2016), making a total of 10 included studies (Bulinska 2016;
Collins 2012; Delaney 2015; Kropielnicka 2018; McDermott 2009;
Regensteiner 1996; Ritta-Dias 2010; Sanderson 2006; Szymczak
2016; Treat-Jacobson 2009). A summary of included studies is
provided in the Characteristics of included studies tables. In these
10 studies, a total of 527 participants with intermittent claudication
(IC) were randomised, of which 488 participants were randomised
to the treatment arms that were relevant to this review. One
study was relatively small involving fewer than 30 participants
(Regensteiner 1996), six studies included more than 30 but fewer
than 70 participants (Delaney 2015; McDermott 2009; Ritta-Dias
2010; Sanderson 2006;, Szymczak 2016;, Treat-Jacobson 2009); and
three studies included 70 or more participants (Bulinska 2016;
Collins 2012; Kropielnicka 2018). The mean age of the participants
in the included studies varied between 62.0 and 73.4 years. All
studies included both men and women, with the percentages of
female participants ranging from 7% to 54%. The studies were
conducted in Australia (2), Brazil (1), Poland (3) and the United
States (4). Nine studies compared supervised walking exercise to
a single alternative mode of exercise, which was lower-extremity
resistance training in four studies (McDermott 2009; Regensteiner
1996; Ritta-Dias 2010; Szymczak 2016), Nordic walking in three
studies (Bulinska 2016; Collins 2012; Kropielnicka 2018), cycling
(Sanderson 2006) and arm ergometry (Treat-Jacobson 2009). Four
studies compared walking exercise to combination treatment,
consisting of walking and lower-extremity resistance training
(Delaney 2015; Regensteiner 1996), walking and arm ergometry
(Treat-Jacobson 2009) and Nordic walking and lower extremity
resistance training (Kropielnicka 2018).
Enrolment criteria were relatively homogeneous. In all studies,
participants were included if a decrease in ankle brachial
index (ABI) was present together with limiting or disabling
symptoms of IC. Two studies (Collins 2012; McDermott
2009) assessed claudication symptoms by a questionnaire
(Edinburgh Claudication Questionnaire and San Diego Claudication
Questionnaire, respectively). McDermott 2009 included both
symptomatic and asymptomatic patients with PAD, however
only the data of participants with IC were included in this
review. Delaney 2015 only included participants with radiographic
evidence of infra-inguinal disease in the absence of aorta-iliac
disease. In all studies, the presence of critical limb ischaemia was an
exclusion criterion. Participants were also excluded if the exercise
capacity was limited by another factor than IC (e.g. angina, chronic
obstructive pulmonary disease, arthrosis) or if they were unable
to perform the exercise programme (e.g. unable to walk on a
treadmill or with Nordic poles). Szymczak 2016 excluded patients
with diabetes and Kropielnicka 2018 excluded participants with
''generally poor health''. In four studies, claudication symptoms
needed to be stable for three months (Kropielnicka 2018;
Regensteiner 1996), six months (Ritta-Dias 2010), or more than 12
months (Sanderson 2006). Four studies excluded participants if a
revascularisation procedure was performed in the previous year
(Delaney 2015; Regensteiner 1996; Ritta-Dias 2010; Szymczak 2016).
Szymczak 2016 excluded participants that suMered from stroke in
the prior six months or had cardiac surgery in the prior 12 months.
Three studies excluded participants if a coronary or lower-extremity
revascularisation procedure was performed within the prior three
months (Bulinska 2016; Kropielnicka 2018; Treat-Jacobson 2009).
Two studies excluded participants in case of a cardiovascular
event in the prior three months (Bulinska 2016); or 12 months
(Kropielnicka 2018). One study excluded patients that participated
in another exercise programme in the prior three weeks (Collins
2012). The two remaining studies excluded participants if they
recently underwent surgery or a cardiovascular event (McDermott
2009; Sanderson 2006). Treatment duration varied between
studies ranging from six weeks training (Sanderson 2006), to 12-
week training (Bulinska 2016; Delaney 2015; Kropielnicka 2018;
Regensteiner 1996; Ritta-Dias 2010; Szymczak 2016; Treat-Jacobson
2009) and 24-week training (Collins 2012; McDermott 2009).
Excluded studies
For this update, six additional studies (six publications) were
excluded based on full-text assessment (Delaney 2014; EXERT
Study 2018; Kao 2012; Oakley 2008; Parmenter 2013; Van
Schaardenburgh 2017).
Overall, 23 studies were excluded based on full-text assessment.
A summary of excluded studies is available in the Characteristics
of excluded studies table. Three studies were excluded because
they were not randomised (or quasi-randomised) controlled trials
(Gardner 2011; Kim 2006; Roitman 2010). Five studies were
excluded because they were meeting posters with a limited
description of the methods and results and no related articles
were published or available aJer contact with the authors (Dedes
2010; Kao 2012; Kuwabara 2010; Ornelas 2011; Treat-Jacobson
2012). Twelve studies were excluded because they did not assess
adequately supervised exercise therapy, according to the inclusion
criteria of this review (Nawaz 2001; Oakley 2008; Parmenter
2013; Parr 2009; Saxton 2008; Saxton 2011; Van Schaardenburgh
2017; Tebbutt 2011; Treat-Jacobson 2012; Walker 2000; Wang
2008; Zwierska 2005). Six studies did not report the primary and
secondary outcome measures of this review (Delaney 2014; Nawaz
2001; Saxton 2008; Saxton 2011; Treat-Jacobson 2011; Walker
2000). One study was excluded because the outcome measures
were not clearly described and we did not receive additional
information upon request (Jones 1996). The previous version of this
review identified the EXERT study as an ongoing study (EXERT Study
2018). Although this study was completed, the original results have
not been published. Only one publication was available comparing
long-term follow-up (one to four years) to end of study results (24
weeks). Baseline data were not available from the authors, so we
have now excluded this study.
Ongoing studies
Two ongoing studies were identified (ACTRN12616000243415;
NCT03837639), for which a summary of study protocols is
available in the Characteristics of ongoing studies table. One study
Modes of exercise training for intermittent claudication (Review)
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(ACTRN12616000243415) has been completed, but the results have
not yet been published or available from the authors (status:
preparing the manuscript for submission to a peer-reviewed
journal).
Risk of bias in included studies
See Figure 2 and Figure 3.
 
Figure 2.   Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages
across all included studies.
Random sequence generation (selection bias)
Allocation concealment (selection bias)
Blinding of participants and personnel (performance bias): All outcomes
Blinding of outcome assessment (detection bias): All outcomes
Incomplete outcome data (attrition bias): All outcomes
Selective reporting (reporting bias)
Other bias
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Bulinska 2016 - - + ? - + ?
Collins 2012 + + + ? ? + +
Delaney 2015 + + + + + + ?
Kropielnicka 2018 - - + ? - + ?
McDermott 2009 + + + + ? + ?
Regensteiner 1996 ? ? + ? + + +
Ritta-Dias 2010 + + + + + + +
Sanderson 2006 + ? + ? + + +
Szymczak 2016 ? ? + ? ? + ?
Treat-Jacobson 2009 + ? + + + + +
 
Allocation
Four studies described adequate sequence generation and
allocation concealment by means of computer randomisation and
so were at low risk of selection bias (Collins 2012; Delaney 2015;
McDermott 2009; Ritta-Dias 2010). Two studies were judged to be
at low risk for randomisation sequence bias but at unclear risk for
allocation concealment as they described an adequate sequence
generation, but did not describe the allocation concealment
(Sanderson 2006; Treat-Jacobson 2009). Two studies were judged
to have high risk of bias because they used a pseudorandomisation
method in which participants were allocated by the investigators
using a fixed block size (Bulinska 2016; Kropielnicka 2018). The two
remaining studies did not describe the randomisation process and
so were at an unclear risk of selection bias (Regensteiner 1996;
Szymczak 2016).
Blinding
In all of the included studies, participants and personnel could not
be blinded to the intervention (exercise). For this reason, bias could
be introduced. However, since all studies experienced the same
limitation, we considered the risk of bias to be low on this domain
for all studies. Detection bias can be avoided by blinding the
outcome assessors, which was achieved by four studies who were
judged to be at low risk of bias (Delaney 2015; McDermott 2009;
Ritta-Dias 2010; Treat-Jacobson 2009). The remaining studies did
not provide information on blinding of outcome assessors and so
were at unclear risk of detection bias (Bulinska 2016; Collins 2012;
Kropielnicka 2018; Regensteiner 1996; Sanderson 2006; Szymczak
2016).
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Incomplete outcome data
Five studies provided well-described reasons for missing data,
which we considered to be plausible and well distributed among
the groups and were at low risk of attrition bias (Delaney
2015; Regensteiner 1996; Ritta-Dias 2010; Sanderson 2006; Treat-
Jacobson 2009). McDermott 2009 included both symptomatic and
asymptomatic participants with PAD. We received the data for
participants with IC upon request. Although the article described
the missing data, it was unclear to what extent they were related to
the group of symptomatic participants. Therefore, we considered
the risk of attrition bias to be unclear. Two studies were judged
to have high risk of attrition bias because missing data were not
balanced across groups and no intention-to-treat analysis was
performed (Bulinska 2016; Kropielnicka 2018). Bulinska 2016 did
not provide reasons for drop-outs, while in the other study the
majority of reasons was directly related to one of the interventions
(Kropielnicka 2018). In Collins 2012, the risk of attrition bias was
considered to be unclear, as the number of drop-outs was high and
not evenly distributed among groups (18 versus 13). Szymczak 2016
did not provide information on incomplete outcome data, and so
was also considered to be at an unclear risk of bias.
Selective reporting
We judged all studies to have low risk of reporting bias
because published reports included all expected outcomes or
because we obtained missing outcomes by contacting the authors
(Bulinska 2016; Collins 2012; Delaney 2015; Kropielnicka 2018;
McDermott 2009; Regensteiner 1996; Ritta-Dias 2010; Sanderson
2006; Szymczak 2016; Treat-Jacobson 2009).
Other potential sources of bias
Since we included only nine studies in the quantitative analysis,
we could not detect publication bias by using a funnel plot. We
considered five studies to potentially have other sources of bias
and so were judged as 'unclear' (Bulinska 2016; Delaney 2015;
Kropielnicka 2018; McDermott 2009; Szymczak 2016). Bulinska 2016
reported significant diMerences in relevant baseline characteristics
(hypertension and degenerative changes of spine and peripheral
joints) which might have aMected outcomes. Delaney 2015
excluded patients with radiographic aortic-iliac disease, but there
is no scientific evidence that confirms a diMerence in treatment
eMects of exercise related to the level of disease. Therefore, this
was also considered as a potential source of bias. McDermott 2009
included both asymptomatic and symptomatic participants with
PAD. Although we only included data of symptomatic participants
in this review, the article provided baseline characteristics for
the total study population (including asymptomatic participants),
which introduces a potential source of bias. In two other
studies, baseline characteristics were either not clearly presented
(Szymczak 2016) or very limited (Kropielnicka 2018). We identified
no other potential sources of bias in the included studies.
E6ects of interventions
See: Summary of findings 1 Alternative modes of exercise
compared to walking exercise for people with intermittent
claudication
Alternative modes of exercise training compared to traditional
walking exercise aKer 12 weeks of training
Maximum walking distance (MWD)
Six studies reported the MWD aJer 12 weeks of training (Bulinska
2016; Kropielnicka 2018; Regensteiner 1996; Ritta-Dias 2010;
Szymczak 2016; Treat-Jacobson 2009), with a total sample size of
274 participants. Overall, there was no clear diMerence detected
between alternative modes of exercise compared to traditional
walking (standardised mean diMerence (SMD) -0.01, 95% CI -0.29
to 0.27; P = 0.95; low-certainty evidence; see Analysis 1.1).
Heterogeneity was considered low (P = 0.28, I2 = 18%). See
Summary of findings 1. Sensitivity analysis was carried out by
removing studies with high risk of bias, as defined in the Sensitivity
analysis section (Bulinska 2016; Kropielnicka 2018; Szymczak
2016), and this had no eMect on the SMD.
We investigated diMerent modes of exercise by subgroup analysis
(see Analysis 1.1). These are summarised below. No diMerences
were detected by the test for subgroup diMerences (P = 0.16).
Lower extremity resistance training versus walking exercise
Three studies reported the MWD aJer 12 weeks of training
(Regensteiner 1996; Ritta-Dias 2010; Szymczak 2016), with a sample
size of 94 participants. No diMerence was detected between the
resistance and walking exercise groups (SMD -0.02, 95% CI -0.59 to
0.55; P = 0.94; Analysis 1.1). Heterogeneity was considered low (I2 =
40%; P = 0.19) and sensitivity analysis had no significant eMect on
the SMD.
Nordic walking versus walking exercise
Two studies compared Nordic walking with walking and reported
MWD aJer 12 weeks of training, with a sample size of 88 participants
(Bulinska 2016; Kropielnicka 2018). The SMD of 0.31 represented
little or no diMerence (95% CI -0.12 to 0.74; P = 0.15; Analysis 1.1).
Heterogeneity was low (I2 = 0%).
Combination of exercise modes versus walking exercise
Three studies with a sample size of 74 participants compared a
combination of exercise modes with walking and reported MWD
aJer 12 weeks of training (Kropielnicka 2018; Regensteiner 1996;
Treat-Jacobson 2009). We found no clear diMerence for MWD (SMD
-0.19, 95% CI -0.66 to 0.29; P = 0.44; Analysis 1.1). Heterogeneity was
low (I2 = 0%).
Arm ergometry versus walking exercise
Only one small study investigated arm ergometry compared
to walking exercise and no clear diMerences were detected in
MWD between the groups (SMD -0.84, 95% CI -1.87 to 0.19; 18
participants; Analysis 1.1) (Treat-Jacobson 2009).
Pain-free walking distance (PFWD)
Five studies reported the PFWD aJer 12 weeks of training (Bulinska
2016; Kropielnicka 2018; Ritta-Dias 2010; Szymczak 2016; Treat-
Jacobson 2009), with a sample size of 249 participants. Pooling did
not detect a diMerence in PFWD between alternative modes and
walking exercise (SMD -0.01, 95% CI -0.26 to 0.25; P = 0.97; low-
certainty evidence; see Analysis 1.2). Heterogeneity was low (I2 =
0%). We carried out sensitivity analysis by removing studies with
a high risk of bias, as defined in the Sensitivity analysis section
Modes of exercise training for intermittent claudication (Review)
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(Bulinska 2016; Kropielnicka 2018; Szymczak 2016), and this had no
eMect on the SMD.
We investigated diMerent modes of exercise by subgroup analysis
(see Analysis 1.2). These are summarised below. No diMerences
were detected by the test for subgroup diMerences (P = 0.39).
Lower extremity resistance training versus walking exercise
Two studies reported the PFWD aJer 12 weeks of training, with a
sample size of 80 participants (Ritta-Dias 2010; Szymczak 2016).
There was no clear diMerence between groups for the pooled PFWD
(SMD 0.11, 95% CI -0.32 to 0.55; P = 0.61; Analysis 1.2). Heterogeneity
was low (I2 = 0%).
Walking versus Nordic walking versus walking exercise
Two studies reported PFWD aJer 12 weeks of training, with a
sample size of 88 participants (Bulinska 2016; Kropielnicka 2018).
No clear diMerence was detected between groups (SMD 0.14, 95%
CI -0.28 to 0.57; P = 0.51; Analysis 1.2). Studies were considered
homogeneous (I2 = 0%).
Combination of exercise modes versus walking exercise
Two studies reported PFWD aJer 12 weeks of training, with a
sample size of 63 participants (Kropielnicka 2018; Treat-Jacobson
2009). Little to no diMerence was found between groups (SMD -0.22,
95% CI -0.74 to 0.30; P = 0.40; Analysis 1.2). Included studies were
considered homogeneous (I2 = 0%).
Arm ergometry versus walking exercise
Only one small study investigated arm ergometry compared
to walking exercise and no clear diMerences were detected in
PFWD between the groups (SMD -0.65, 95% CI -1.66 to 0.36; 18
participants; Analysis 1.2) (Treat-Jacobson 2009).
Alternative modes of exercise training compared to traditional
walking exercise at end of training
Maximum walking distance (MWD)
Nine studies reported the MWD at the end of training with a
total sample size of 412 participants (Bulinska 2016; Collins 2012;
Kropielnicka 2018; McDermott 2009; Regensteiner 1996; Ritta-Dias
2010; Sanderson 2006; Szymczak 2016; Treat-Jacobson 2009). The
duration of exercise programmes varied from 6 to 24 weeks. Pooling
detected no clear diMerence between groups (SMD -0.11, 95% CI
-0.33 to 0.11; P = 0.32; low-certainty evidence, see Analysis 2.1). The
impact of heterogeneity was considered to be low (P = 0.30; I2 =
15%). Sensitivity analysis was carried out by removing studies at
risk of bias (Bulinska 2016; Kropielnicka 2018; Szymczak 2016), and
resulted in a small to moderate eMect on MWD in favour of walking
exercise, with a SMD of -0.36 (95% CI -0.63 to -0.10; P = 0.008; I2 =
0%) (Figure 4).
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Figure 4.   Alternative modes of exercise training compared to traditional walking exercise at end of training:
maximum walking distance (MWD). Sensitivity analysis: excluding studies at risk of bias (Bulinska 2016;
Kropielnicka 2018; Szymczak 2016)
 
We investigated diMerent modes of exercise by subgroup analysis
(see Analysis 2.1). These are summarised below. No clear
diMerences were detected by the test for subgroup diMerences (P =
0.62).
Lower extremity resistance training versus walking exercise
Four studies reported the MWD at the end of training with a
sample size of 127 participants (McDermott 2009; Regensteiner
1996; Ritta-Dias 2010; Szymczak 2016). The duration of exercise
programmes varied from 12 to 24 weeks. There was no clear
diMerence in MWD (SMD -0.06, 95% CI -0.48 to 0.35; P = 0.77; Analysis
2.1). Heterogeneity was considered low (P = 0.27; I2 = 24%) and
sensitivity analysis had no significant eMect on the SMD.
Nordic walking versus walking exercise
Three studies reported MWD at the end of training, with a sample
size of 165 participants and programme duration varying from 12
to 24 weeks (Bulinska 2016; Collins 2012; Kropielnicka 2018). No
clear diMerence was found (SMD 0.04, 95% CI -0.47 to 0.54; P =
0.88; Analysis 2.1). The moderate heterogeneity (P = 0.08, I2 = 60%)
seemed largely due to one study (Collins 2012). Sensitivity analysis
to exclude this trial did result in statistical homogeneity, but did not
significantly alter the SMD.
Combination of exercise modes versus walking exercise
Three studies compared combination of exercise modes with
walking exercise (Kropielnicka 2018; Regensteiner 1996; Treat-
Jacobson 2009). As all three studies had a training duration of 12
weeks, results are reported above (Analysis 1.1).
Arm ergometry versus walking exercise
Only Treat-Jacobson 2009 compared arm ergometry with walking
exercise. As the training duration was 12 weeks, results are reported
above (Analysis 1.1).
Cycling versus walking exercise
Only one small study with 28 participants compared cycling to
walking exercise and no diMerences were detected in MWD between
the groups (SMD -0.31, 95% CI -1.06 to 0.43; P = 0.41; Analysis 2.1)
(Sanderson 2006).
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Pain-free walking distance (SMDs)
Eight studies reported the PFWD at the end of training with
a sample size of 382 participants (Bulinska 2016; Collins 2012;
Kropielnicka 2018; McDermott 2009; Ritta-Dias 2010; Sanderson
2006; Szymczak 2016; Treat-Jacobson 2009). The duration of
exercise programmes varied from 6 to 24 weeks. There was no
clear diMerence between groups with a small SMD of -0.06 (95% CI
-0.30 to 0.17; P = 0.59; low-certainty evidence, see Analysis 2.2). The
heterogeneity of included studies was considered low (P = 0.24, I2
= 22%). Sensitivity analysis by removing studies with a risk of bias
did not alter the SMD (Bulinska 2016; Kropielnicka 2018; Szymczak
2016).
We investigated diMerent modes of exercise by subgroup analysis
(see Analysis 2.2). These are summarised below. The test for
subgroup diMerences detected a diMerence (P = 0.04, I2 = 60.4%),
which seemed to be caused by the cycling subgroup that included
only one study (Sanderson 2006). AJer removing this study, no
subgroup diMerences were detected (P = 0.27, I2 = 23.5%).
Lower extremity resistance training versus walking exercise
Three studies reported PFWD at the end of training, with a
sample size of 108 participants (McDermott 2009; Ritta-Dias 2010;
Szymczak 2016). The duration of exercise programmes varied from
12 to 24 weeks. There was no clear diMerence between groups (SMD
0.01; 95% CI -0.37 to 0.38; P = 0.98; Analysis 2.2). The included
studies were considered homogeneous (I2 = 0%) and sensitivity
analyses had no important eMect on the SMD.
Nordic walking versus walking exercise
Three studies reported PFWD at the end of training, with a sample
size of 165 participants and programme duration varying from 12 to
24 weeks (Bulinska 2016; Collins 2012; Kropielnicka 2018). The SMD
of 0.21 represented little to no diMerence between groups (95% CI
-0.10 to 0.52; P = 0.19). Studies were considered homogeneous (I2
= 0%).
Combination of exercise modes versus walking exercise
Two studies compared combination of exercise modes with walking
exercise (Kropielnicka 2018; Treat-Jacobson 2009). As these had a
training duration of 12 weeks, results are reported above (Analysis
1.2).
Arm ergometry versus walking exercise
Only Treat-Jacobson 2009 compared arm ergometry with walking
exercise. As the training duration was 12 weeks, results are reported
above (Analysis 1.2).
Cycling versus walking exercise
Only one small study with 28 participants investigated cycling
compared to walking exercise and a possible benefit from walking
exercise may be seen in PFWD between the groups (SMD -1.01, 95%
CI -1.81 to -0.22; P = 0.01; Analysis 2.2) (Sanderson 2006).
Health-related quality of life (HR-QoL)
Four studies described HR-QoL (Collins 2012; Delaney 2015;
McDermott 2009; Regensteiner 1996). Two studies reported the
physical functioning score of the SF-36 (Collins 2012; McDermott
2009). Because of the skewed data of one of the studies (McDermott
2009), with relatively small sample size, we did not perform
a meta-analysis. Both studies found an improvement in both
exercise groups. In McDermott 2009, the physical functioning score
improved to a median score of 50.0 (interquartile range 40.0 to 60.0)
aJer 24 weeks of treadmill walking (n = 17) and to a median score
of 60.0 (interquartile range 35.0 to 70.0) aJer strength training (n =
14, P = 0.811). In Collins 2012, the mean score was 60.42 (SD 21.75)
aJer 24 weeks of treadmill walking (n = 43) and 55.51 (SD 21.27)
aJer Nordic walking (n = 34, P = 0.22).
Regensteiner 1996, with a sample size of 25 participants, used
the Medical Outcomes Study (MOS) SF-20, which consists of five
domain scores: physical functioning score, social functioning score,
role functioning score, overall health score, and well-being score.
AJer 12 weeks of training, the physical functioning scores improved
by 24% for the walking group (95% CI 9 to 39), and the well-being
scores increased by 9% (95% CI 2 to 16) for the lower-extremity
resistance training group. No improvement in the other MOS
domains was detected. In the combined group, no improvement in
MOS scores was seen.
Delaney 2015 used the Australian Vascular Quality of Life Index, in
which a lower score represents higher quality of life. It found an
improved HR-QoL in both the treadmill walking group (n = 15) and
the combination exercise group (n = 12), with a mean decrease of
1.6 points (SD 2.4) and 3.3 points (SD 3.9), respectively (P = 0.18).
Self-reported functional impairment
Three studies used the WIQ to measure functional impairment
(Collins 2012; McDermott 2009; Regensteiner 1996). All three
studies reported the WIQ distance score and two studies also
reported the speed and stair-climbing scores (McDermott 2009;
Regensteiner 1996). One study had relatively small sample size
and a non-normal distribution of outcomes (McDermott 2009).
Therefore, it was considered inappropriate to transform these
skewed data to enable pooling. Meta-analysis of the two remaining
studies, with a sample size of 96 participants, showed little or no
diMerence between the study arms, with a mean diMerence of -5.52
(95% CI -17.41 to 6.36, P = 0.36; low-certainty evidence; see Analysis
2.3). The included studies were considered homogeneous (I2 = 0%).
In McDermott 2009, the WIQ distance score improved in both the
strength (n = 15) and treadmill walking group (n = 15), with a
median of, respectively, 14.0 points (interquartile range = 1.56
to 26.6) and 7.46 points (interquartile range = -0.36 to 25.0; P =
0.431). WIQ speed score improved in both the strength (n = 15) and
treadmill walking group (n = 16), with a median of, respectively,
3.26 points (interquartile range = -7.61 to 26.1) and 1.63 points
(interquartile range = -3.80 to 28.8; P = 0.736). WIQ stair-climbing
score improved in the strength training group (n = 15), with a
median of, respectively, 12.5 points (interquartile range = 4.17 to
25.0), while no improvement was seen in the median score in
the treadmill walking group (n = 16, median score of 0.00 points,
interquartile range = 0.00 to 14.6; P = 0.136). Finally, the remaining
study (Regensteiner 1996), showed little or no diMerence in the WIQ
speed score with an eMect size of -4.50% (95% CI -27.34 to 18.34;
P = 0.70) and a decreased WIQ stair-climbing score with an eMect
size of -29.50% (95% CI -51.65 to -7.35, P = 0.009), both in favour of
alternative exercise.
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D I S C U S S I O N
Summary of main results
See Summary of findings 1.
In this update, five additional studies were included, making a
total of 10 studies that randomised a total of 527 participants.
The alternative modes of exercise therapy included cycling,
lower-extremity resistance training, upper-arm ergometry, Nordic
walking, and combinations of exercise modes. Besides randomised
controlled trials, two quasi-randomised trials were included. Our
assessment of the overall risk of bias of included studies varied from
high to low risk of bias. Using the GRADE criteria, the certainty of
evidence was judged to be low due to the relatively small sample
sizes, clinical inconsistency, and inclusion of three studies with risk
of bias concerns.
Overall, no clear diMerences were detected between alternative
exercise modes and walking exercise for mean walking distance
(MWD) at 12 weeks (standardised mean diMerence (SMD) -0.01, 95%
CI -0.29 to 0.27; P = 0.95; 6 studies; 274 participants; low-certainty
evidence); or at the end of training (SMD -0.11, 95% CI -0.33 to
0.11; P = 0.32; 9 studies; 412 participants; low-certainty evidence).
Similarily, no clear diMerences were detected for PFWD at 12 weeks
(SMD -0.01, 95% CI -0.26 to 0.25; P = 0.97; 5 studies; 249 participants;
low-certainty evidence) or at the end of training (SMD -0.06, 95%
CI -0.30 to 0.17; P = 0.59; 8 studies, 382 participants; low-certainty
evidence).
Four studies reported on HR-QoL and three studies reported on
functional impairment. However, meta-analysis was only possible
for the WIQ distance score, which demonstrated little or no
important diMerence between study groups (MD -5.52, 95% CI
-17.41 to 6.36; P = 0.36; 2 studies; 96 participants; low-certainty
evidence).
We carried out subgroup analyses by type of alternative exercise
mode (cycling, lower-extremity resistance training, upper-arm
ergometry, Nordic walking, and combinations of exercise modes)
for the main outcomes of MWD and PFWD at 12 weeks and
end of training. No diMerences were detected by the test for
subgroup diMerences in MWD or PFWD at 12 weeks (P = 0.16;
P = 0.39; respectively). At the end of training, no diMerence
was detected between the subgroups for MWD (P = 0.62); but a
diMerence was detected in PFWD (P = 0.04), which seemed to be
caused by the cycling subgroup that included only one study with
28 participants (Sanderson 2006). AJer removing this study, no
subgroup diMerences were detected (P = 0.27, I2 = 23.5%).
Sensitivity analysis did not significantly alter the results, except
for the primary comparison of MWD at the end of training. In this
comparison, excluding studies with apparent risk of bias resulted
in a small to moderate eMect on MWD in favour of walking exercise
(SMD -0.36, 95% CI -0.63 to -0.10; P = 0.0008; 5 studies; 230
participants; low-certainty evidence). This might suggest that, in
the absence of the influence of bias, walking exercise interventions
provide more benefit for MWD at the end of intervention compared
to alternative modes of exercise. The use of SMDs makes it
diMicult to determine whether the diMerence was clinically relevant.
Interpretation is further complicated by the fact that the alternative
exercise group includes diMerent types of exercises. Moreover, our
level of certainty regarding this evidence is low considering it was
from a small number of studies with relatively small sample size.
Future research is likely to have a relevant impact on our confidence
in the estimate of eMect.
Overall completeness and applicability of evidence
Although the subject of this review is increasing in interest, only
five new studies could be included since the previous search of July
2013. In addition to this, we have identified some possible factors
which may limit the completeness and applicability of the evidence
presented:
Participants
The enrolment criteria were relatively homogeneous among
included studies. All studies excluded participants if the exercise
capacity was limited by comorbidity. However, comorbidity is
common among patients with IC, as they are mostly elderly.
Therefore, excluding participants with comorbidity probably
aMects the generalisability of the observed eMects.
Interventions
The vast majority of studies met the guidelines' recommendations
for a minimum programme duration of 12 weeks, with durations
ranging from six weeks (Sanderson 2006), to 12 weeks (Bulinska
2016; Delaney 2015; Kropielnicka 2018; Regensteiner 1996; Ritta-
Dias 2010; Szymczak 2016; Treat-Jacobson 2009), and 24 weeks
(Collins 2012, McDermott 2009). The included studies reported
outcomes on five alternative modes of exercise, namely cycling
(Sanderson 2006), lower-extremity resistance training (McDermott
2009; Regensteiner 1996; Ritta-Dias 2010; Szymczak 2016), upper-
arm ergometry (Treat-Jacobson 2009), Nordic walking (Bulinska
2016; Collins 2012; Kropielnicka 2018), and combinations of
exercise modes (Kropielnicka 2018; Regensteiner 1996; Treat-
Jacobson 2009). Subgroup analysis was carried out with the
available data but each subgroup included a small number of
studies. Overall, more studies are needed to make meaningful
comparisons between each alternative exercise mode and the
current standard of walking exercise.
Outcomes
Only a few studies reported HR-QoL (Collins 2012; Delaney 2015;
McDermott 2009; Regensteiner 1996), using diMerent measuring
instruments, and self-reported functional impairment (Collins
2012; McDermott 2009; Regensteiner 1996). Meta-analysis was only
possible for one of the WIQ subscores. Therefore, more studies are
needed to make meaningful comparisons for these outcomes.
Applicability
For the overall meta-analysis, the sample size seemed suMicient,
but the results should be interpreted with caution because of
the risk of bias ranging from high to low and heterogeneity
due to the diMerent types of alternative interventions included
and the diMerent units of outcomes across studies. Participant
numbers for the subgroup analyses were limited. The SMDs were
not back-transformed to metres or seconds, because this could
be misleading and there is no consensus in the literature on a
minimum clinically relevant diMerence in metres. Using the rules of
thumb for eMect sizes might simplify interpretation of the results
(SMD of 0.2 represents a small eMect, 0.5 a moderate eMect, and 0.8
a large eMect).
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The approach chosen in this review has two main limitations
that need to be considered. DiMerent types of interventions were
lumped together given that our primary aim was to compare
alternative modes of exercise to traditional treadmill walking,
and the small number of studies looking at diMerent modes of
exercises complicated subanalysis. Furthermore, a non-inferiority
approach would have been ideal, but this was not feasible
due to the mixed alternative modes of exercise group and the
impossibility of predetermining a substantiated non-inferiority
margin. Despite these limitations, this updated review provides
valuable information.
This review focused on treadmill walking distances. However,
treadmill walking does not necessarily correlate to walking ability
in daily life (Gommans 2016), nor does an increased treadmill
walking distance always lead to more walking (Fokkenrood 2015).
Additionally, a possible training eMect of treadmill walking might
aMect treadmill testing, which probably causes an underestimation
of the eMect of alternative exercise modes. Because of these
aspects, focusing on treadmill walking capacity alone probably
has limited value in optimising the treatment of IC. Moreover,
improving physical fitness and reducing cardiovascular risk, e.g.
by increasing physical activity, are important treatment goals in
IC. Therefore, objective measurements of functional impairment,
physical activity, and physical condition might be interesting,
provided that they are measured with validated measuring
instruments. Unfortunately, the current lack of consensus and
availability of reliable instruments leads to a high heterogeneity
with regard to the use of measuring instruments and outcomes.
Quality of the evidence
The risk of bias of included studies varied from high to low and three
studies were considered to have risk of bias concerns (Bulinska
2016; Kropielnicka 2018; Szymczak 2016) (see Figure 2 and Figure
3). This review demonstrates that alternative modes of exercise
therapy seem to yield similar results to walking therapy and may
be considered useful when supervised walking exercise is not an
option for the patient. The certainty of the evidence according to
the GRADE criteria was low for the overall comparison of alternative
exercise modes versus walking exercise (Summary of findings
1). The certainty was downgraded due to the relatively small
sample sizes, clinical inconsistency, and concerns over risk of bias.
Furthermore, we could not investigate possible publication bias,
because the limited number of studies did not allow for assessment
of asymmetry in funnel plots.
Potential biases in the review process
We used the SMD as a summary statistic to reduce potential
heterogeneity due to the use of diMerent treadmill protocols
between studies. Furthermore, we performed subgroup analyses
if data were available. It was not possible to conduct a formal
analysis of possible publication bias by using a funnel plot owing
to the limited number of studies included in the meta-analysis.
Several studies were excluded, solely because they did not report
the correct outcome measures. Although we carefully ascertained
that relevant outcomes were not available because they were not
measured rather than not reported, this could introduce bias in the
review process. In future updates, we will pay further attention to
this potential source of bias.
Many studies were excluded in the title-abstract screening, because
they were not RCTs, examined nonsupervised programmes or
compared alternative modes of exercise to a non-exercise control
group. Furthermore, this review only included supervised exercise
programmes, thus excluding home-based or partially supervised
programmes comparing walking exercise to alternative modes
of exercise. However, considering the findings of other studies,
this did not substantially alter results (see Agreements and
disagreements with other studies or reviews).
Agreements and disagreements with other studies or
reviews
The findings of this update are in line with the findings of the
previous version of this review (Lauret 2014), as well as findings
of several other systematic reviews. One previously published
systematic review (Parmenter 2011), which included unsupervised
exercise programmes and RCTs with a non-exercise control group,
found no clear diMerence between alternative aerobic exercise
modes and walking exercise for IC. The data on resistance training
were considered insuMicient to make clinical recommendations
and further research was needed. A systematic review and meta-
analysis on Nordic walking (Golledge 2018) suggested that Nordic
walking might be more eMective in improving cardiovascular fitness
than standard walking. However, no benefit of Nordic walking was
found compared to standard walking, including unsupervised and
supervised settings. A subgroup analysis of completely supervised
programmes also demonstrated similar improvements in MWD
(SMD -0.79; 95% CI -2.81 to 1.24; P = 0.446). Furthermore, a recent
statement from the American Heart Association (Treat-Jacobson
2019), was based on a systematic review, which included the
comparison of treatment modalities. Evidence for each of the
alternative exercise modes was summarised separately, and the
authors concluded that modalities other than supervised treadmill
exercise, including arm ergometry, cycling, and possibly resistance
training, can also improve relevant outcomes. In summary, our
findings agree with currently available evidence that alternative
exercise modes are as eMective as standard walking, however, more
evidence is needed.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
Overall, this review demonstrates that there is no clear diMerence
between alternative modes of exercise and supervised walking
exercise regarding maximum and pain-free walking distance in
patients with intermittent claudication, which means that both
interventions yield similar improvements. The certainty of this
evidence was judged to be low, mainly due to the small sample
size and risk of bias concerns. The findings of this review indicate
that alternative exercise modes may be useful when supervised
walking exercise is not an option. This is consistent with current
international guidelines (Aboyans 2018; Gerhard-Herman 2017).
Implications for research
Although this update included five additional studies, the overall
sample size was relatively small. More RCTs with adequate
methodological quality and suMicient power are needed to
provide more robust evidence for comparisons between each
alternative exercise mode and the current standard of supervised
treadmill walking. Those RCTs should preferably investigate
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exercise programmes with a minimum of three sessions a week
for a consecutive 12 weeks, as this is recommended based
on currently available evidence (Treat-Jacobson 2019). Walking
capacity should not solely be measured with treadmill tests, as
this might result in an underestimation of the eMect of alternative
exercise modes and probably does not represent 'daily life' walking.
Future studies should investigate functional outcome measures
on walking behaviour, physical activity, cardiovascular risk,
and HR-QoL, using standardised testing methods and reporting
of outcomes to allow meaningful comparison across studies.
Furthermore, studies should include patients with comorbidity in
order to be more representative of the PAD population. Finally,
research is needed to explore possibilities to optimise exercise
programmes, taking into account the personal preferences, therapy
compliance, and long-term eMects. It is thought that more varied
and personalised programmes will possibly improve therapy
adherence. Furthermore, this might lead to better compliance with
the recommendations for physical activity, because combinations
of aerobic and muscle-strengthening activities are preferable,
according to the Physical Activity Guidelines (Piercy 2018).
A C K N O W L E D G E M E N T S
We acknowledge the support provided by Dr Marlene Stewart,
Managing Editor of Cochrane Vascular, Dr Cathryn Broderick,
Assistant Managing Editor of Cochrane Vascular, and Ms Candida
Fenton, Cochrane Vascular Information Specialist, in updating this
review. We would also like to thank the previous authors for their
contributions to the previous version of this review: Professor
Hunink and Dr Spronk. The review authors, and the Cochrane
Vascular editorial base, wish to thank the following peer reviewers
for their input as well as the reviewer who opted to remain
anonymous: Dr Ralph G DePalma, Uniformed Services University
of the Health Sciences, Washington and Department of Veteran
AMairs, Washington, US; Associate Professor Anthony Leicht, James
Cook University, Australia; Dr Jonathan Moran, Trinity College
Dublin, Ireland; LeAnne Lovett-Floom, DNP, MSN, RN, PHN-BC, US.
Modes of exercise training for intermittent claudication (Review)









Cochrane Database of Systematic Reviews
R E F E R E N C E S
 
References to studies included in this review
Bulinska 2016 {published data only}
Bulinska K, Kropielnicka K, Jasinski T, Wojcieszczyk-Latos J,
Pilch U, Dabrowska G, et al. Nordic pole walking improves
walking capacity in patients with intermittent claudication:
a randomized controlled trial. Disability and Rehabilitation
2016;38(13):1318-24. [PMID: 26305413]
Collins 2012 {published data only}
Collins EG, McBurney C, Butler J, Jelinek C, O'Connell S,
Fritschi C, et al. The eMects of walking or walking-with-poles
training on tissue oxygenation in patients with peripheral
arterial disease. International Journal of Vascular Medicine
2012;2012:985025. [PMID: 23050152]
*  Collins EG, O'Connell S, McBurney C, Jelinek C, Butler J,
Reda D, et al. Comparison of walking with poles and traditional
walking for peripheral arterial disease rehabilitation.
Journal of Cardiopulmonary Rehabilitation and Prevention
2012;32(4):210-8. [PMID: 22595894]
Delaney 2015 {published data only}
Delaney CL, Miller MD, Allan RB, Spark JI. The impact of
diMerent supervised exercise regimens on endothelial
function in patients with intermittent claudication. Vascular
2015;23(6):561-9. [PMID: 25406267]
Kropielnicka 2018 {published data only}
Kropielnicka K, Dziubek W, Bulinska K, Stefanska M,
Wojcieszczyk-Latos J, Jasinski R, et al. Influence of the
physical training on muscle function and walking distance in
symptomatic peripheral arterial disease in elderly. BioMed
Research International 2018;2018:1937527. [PMID: 30345295]
McDermott 2009 {published data only}
*  McDermott MM, Ades P, Guralnik JM, Dyer A, Ferrucci L, Liu K,
et al. Treadmill exercise and resistance training in patients
with peripheral arterial disease with and without intermittent
claudication: a randomized controlled trial. Journal of the
American Medical Association 2009;301(2):165-74. [PMID:
19141764]
McDermott MM, Kibbe MR, Guralnik JM, Ferrucci L, Criqui MH,
Domanchuk K, et al. Durability of benefits from supervised
treadmill exercise in people with peripheral artery disease.
Journal of the American Heart Association 2019;8(1):e009380.
[PMID: 30587066]
Regensteiner 1996 {published data only}
Hiatt WR, Regensteiner JG, Wolfel EE, Carry MR, Brass EP.
EMect of exercise training on skeletal muscle histology and
metabolism in peripheral arterial disease. Journal of Applied
Physiology 1996;81(2):780-8. [PMID: 8872646]
Hiatt WR, Wolfel EE, Meier RH, Regensteiner JG. Superiority of
treadmill walking exercise versus strength training for patients
with peripheral arterial disease. Implications for the mechanism
of the training response. Circulation 1994;90(4):1866-74. [PMID:
7923674]
*  Regensteiner JG, Steiner JF, Hiatt WR. Exercise training
improves functional status in patients with peripheral arterial
disease. Journal of Vascular Surgery 1996;23(1):104-15. [PMID:
8558725]
Ritta-Dias 2010 {published data only}
Grizzo Cucato G, De Moraes Forjaz CL, Kanegusuku H, Da Rocha
Chechuen M, Riani Costa LA, Wolosker N, et al. EMects of walking
and strength training on resting and exercise cardiovascular
responses in patients with intermittent claudication. Vasa
2011;40(5):390-7. [PMID: 21948782]
Menêses AL, De Lima GH, Forjaz CL, Lima AH, Silva GQ,
Cucato GG, et al. Impact of a supervised strength training or
walking training over a subsequent unsupervised therapy
period on walking capacity in patients with claudication.
Journal of Vascular Nursing 2011;29(2):81-6. [PMID: 21558030]
*  Ritti-Dias RM, Wolosker N, De Moraes Forjaz CL, Carvalho CR,
Cucato GG, Leão PP, et al. Strength training increases walking
tolerance in intermittent claudication patients: randomized
trial. Journal of Vascular Surgery 2010;51(1):89-95. [PMID:
19837534]
Sanderson 2006 {published data only}
Sanderson B, Askew C, Stewart I, Walker P, Gibbs H, Green S.
Short-term eMects of cycle and treadmill training on exercise
tolerance in peripheral arterial disease. Journal of Vascular
Surgery 2006;44(1):119-27. [PMID: 16828435]
Szymczak 2016 {published data only}
Szymczak M, Oszkinis G, Majchrzycki M. The impact of walking
exercises and resistance training upon the walking distance in
patients with chronic lower limb ischaemia. BioMed Research
International 2016;2016:7515238. [PMID: 27833919]
Treat-Jacobson 2009 {published data only}
Bronas UG, Treat-Jacobson D, Leon AS. Comparison of the
eMect of upper body ergometry aerobic training vs treadmill
training on central cardiorespiratory improvement and walking
distance in patients with claudication. Journal of Vascular
Surgery 2011;53(6):1557-64. [PMID: 21515017]
*  Treat-Jacobson D, Bronas UG, Leon AS. EMicacy of arm-
ergometry versus treadmill exercise training to improve walking
distance in patients with claudication. Vascular Medicine
2009;14(3):203-13. [PMID: 19651669]
 
References to studies excluded from this review
Dedes 2010 {published data only}
Dedes H, Figoni SF, Kalioundji G, Kunkel C, Peter A, Phillips A, et
al. Prospective trial of calf ergometry training on walking ability
in peripheral arterial disease. PM & R: Journal of Injury, Function,
and Rehabilitation 2010;2(9 Suppl 1):S26.
Delaney 2014 {published data only}
*  Delaney CL, Miller MD, Chataway TK, Spark JI. A randomised
controlled trial of supervised exercise regimens and their
Modes of exercise training for intermittent claudication (Review)









Cochrane Database of Systematic Reviews
impact on walking performance, skeletal muscle mass and
calpain activity in patients with intermittent claudication.
European Journal of Vascular and Endovascular Surgery
2014;47(3):304-10. [PMID: 24445084]
Delaney CL, Spark JI. A randomised controlled trial of two
supervised exercise regimens and their impact on inflammatory
burden in patients with intermittent claudication. Vascular
2016;24(3):264-72. [PMID: 26567275]
EXERT Study 2018 {published data only}
Kirk LN, Brown R, Treat-Jacobson D. Long-term outcomes of
supervised exercise in peripheral artery disease: impact of
diMering modes of exercise 1-4 years aJer intervention. Journal
of Vascular Nursing 2018;36(3):121-8. [PMID: 30139449]
*  NCT00895635. Evaluating two exercise training programs to
reduce leg pain in people with peripheral arterial disease (the
EXERT study). clinicaltrials.gov/ct2/show/NCT00895635 (first
received 8 May 2009).
Gardner 2011 {published data only}
Gardner AW. Supervised exercise therapy provided by local
physiotherapists improves walking distance in patients with
claudication. Evidence-based Medicine 2011;16(2):43-4. [PMID:
21427053]
Jones 1996 {published data only}
Jones PP, Skinner JS, Smith LK, John FM, Bryant CX. Functional
improvements following Stairmaster versus treadmill exercise
training for patients with intermittent claudication. Journal
of Cardiopulmonary Rehabilitation 1996;16(1):47-55. [PMID:
8907442]
Kao 2012 {published data only}
Kao K, Choi S, Etnyre G, Figoni SF, Kunkel CF, Ornelas CC,
et al. Comparison of calf exercise and treadmill training in
peripheral arterial disease. PM & R: Journal of Injury, Function,
and Rehabilitation 2012;4(10):S346.
Kim 2006 {published data only}
Kim DH. Exercise and peripheral arterial disease. Annals of
Internal Medicine 2006;144(9):author reply 699-700. [PMID:
16670144]
Kuwabara 2010 {published data only}
Kuwabara M, Anzai H, Nishi Y, Hayashida N, Hisatome I.
Treadmill and ergometer exercise once a week equally
improve not only exercise-tolerance but also cardio-renal
function in peripheral arterial disease (PAD) patients
with claudication. Journal of the American College of
Cardiology 2010;55(10s1):E1479-A158. [DOI: 10.1016/
S0735-1097(10)61480-5]
Nawaz 2001 {published data only}
Nawaz S, Walker RD, Wilkinson CH, Saxton JM, Pockley AG,
Wood RF. The inflammatory response to upper and lower limb
exercise and the eMects of exercise training in patients with
claudication. Journal of Vascular Surgery 2001;33(2):392-9.
[PMID: 11174795]
Oakley 2008 {published data only}
Oakley C, Zwierska I, Tew G, Beard JD, Saxton JM. Nordic
poles immediately improve walking distance in patients with
intermittent claudication. European Journal of Vascular and
Endovascular Surgery 2008;36(6):689-94; discussion 695-6.
[PMID: 18835794]
Ornelas 2011 {published data only}
Ornelas CC, Dhingsa K, Etnyre G, Figoni SF, Fung DA, Kunkel C, et
al. Comparison of calf ergometer and treadmill exercise training
interventions for participants with intermittent claudication
due to peripheral arterial disease. PM & R: Journal of Injury,
Function, and Rehabilitation 2011;3(10 Suppl 1):S266-7. [DOI:
10.1016/j.pmrj.2011.08.302]
Parmenter 2013 {published data only}
Parmenter BJ, Raymond J, Dinnen P, Lusby RJ, Fiatarone
Singh MA. High-intensity progressive resistance training
improves flat-ground walking in older adults with symptomatic
peripheral arterial disease. Journal of the American Geriatrics
Society 2013;61(11):1964-70.
Parr 2009 {published data only}
Parr BM, Noakes TD, Derman EW. Peripheral arterial disease
and intermittent claudication: eMicacy of short-term upper
body strength training, dynamic exercise training, and
advice to exercise at home. South African Medical Journal
2009;99(11):800-4. [PMID: 20218480]
Roitman 2010 {published data only}
Roitman JL. Treadmill exercise and resistance training in
patients with peripheral arterial disease with and without
intermittent claudication: a randomized controlled trial.
Journal of Cardiopulmonary Rehabilitation and Prevention
2010;30(1):62.
Saxton 2008 {published data only}
Saxton JM, Zwierska I, Hopkinson K, Espigares E, Choksy S,
Nawaz S, et al. EMect of upper- and lower-limb exercise training
on circulating soluble adhesion molecules, hs-CRP and stress
proteins in patients with intermittent claudication. European
Journal of Vascular and Endovascular Surgery 2008;35(5):607-13.
[PMID: 18226561]
Saxton 2011 {published data only}
Saxton JM, Zwierska I, Blagojevic M, Choksy SA, Nawaz S,
Pockley AG. Upper- versus lower-limb aerobic exercise training
on health-related quality of life in patients with symptomatic
peripheral arterial disease. Journal of Vascular Surgery
2011;53(5):1265-73. [PMID: 21215558]
Tebbutt 2011 {published data only}
Tebbutt N, Robinson L, Todhunter J, Jonker L. A plantar flexion
device exercise programme for patients with peripheral
arterial disease: a randomised prospective feasibility study.
Physiotherapy 2011;97(3):244-9. [PMID: 21820543]
Treat-Jacobson 2011 {published data only}
Treat-Jacobson D, Henly SJ, Bronas UG, Leon AS, Henly GA.
The pain trajectory during treadmill testing in peripheral artery
Modes of exercise training for intermittent claudication (Review)









Cochrane Database of Systematic Reviews
disease. Nursing Research 2011;60(3 Suppl):S38-49. [PMID:
21543960]
Treat-Jacobson 2012 {published data only}
Treat-Jacobson D, Bronas UG, Krause BJ, Robinson CA,
Santilli SM, Leon AS. Aerobic arm exercise training to improve
outcomes for patients with severe claudication and ischemic
rest pain. Vascular Medicine 2012;17(3):204.
Van Schaardenburgh 2017 {published data only}
Van Schaardenburgh M, Wohlwend M, Rognmo O, Mattsson EJR.
Exercise in claudicants increase or decrease walking ability
and the response relates to mitochondrial function. Journal of
Translational Medicine 2017;15(1):130. [PMID: 28592294]
Walker 2000 {published data only}
Walker RD, Nawaz S, Wilkinson CH, Saxton JM, Pockley AG,
Wood RF. Influence of upper- and lower-limb exercise training
on cardiovascular function and walking distances in patients
with intermittent claudication. Journal of Vascular Surgery
2000;31(4):662-9. [PMID: 10753273]
Wang 2008 {published data only}
Wang E, HoM J, Loe H, Kaehler N, Helgerud J. Plantar flexion:
an eMective training for peripheral arterial disease. European
Journal of Applied Physiology 2008;104(4):749-56. [PMID:
18726111]
Zwierska 2005 {published data only}
Zwierska I, Walker RD, Choksy SA, Male JS, Pockley AG,
Saxton JM. Upper- vs lower-limb aerobic exercise rehabilitation
in patients with symptomatic peripheral arterial disease:
a randomized controlled trial. Journal of Vascular Surgery
2005;42(6):1122-30. [PMID: 16376202]
 
References to ongoing studies
ACTRN12616000243415 {published data only}
ACTRN12616000243415. Comparison of the eMects of
supervised treadmill walking training and supervised
walking with poles on functional capabilities in patients with
intermittent claudication. anzctr.org.au/Trial/Registration/
TrialReview.aspx?id=369663 (first received 23 November 2015).
NCT03837639 {published data only}
NCT03837639. Arm-crank exercise training on cardiovascular
function of patients with peripheral artery disease.





Aboyans V, Ricco JB, Bartelink MEL, Bjorck M, Brodmann M,
Cohnert T, et al. Editor's Choice - 2017 ESC Guidelines on the
diagnosis and treatment of peripheral arterial diseases, in
collaboration with the European Society for Vascular Surgery
(ESVS). European Journal of Vascular and Endovascular Surgery
2018;55(3):305-68. [PMID: 28851596]
Atkins 2004
Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al.
Grading quality of evidence and strength of recommendations.
British Medical Journal 2004;328(7454):1490-4.
Bendermacher 2007
Bendermacher BL, Willigendael EM, Nicolaï SP, Kruidenier LM,
Welten RJ, Hendriks E, et al. Supervised exercise therapy
for intermittent claudication in a community-based setting
is as eMective as clinic-based. Journal of Vascular Surgery
2007;45(6):1192-6. [PMID: 17543684]
Cohen 1988
Cohen J. Statistical Power Analysis in the Behavioral Sciences.
2nd edition. Hillsdale (NJ): Lawrence Erlbaum Associates, Inc,
1988.
Conte 2015
Conte MS, Pomposelli FB, Clair DG, Geraghty PJ, McKinsey JF,
Mills JL, et al. Society for Vascular Surgery practice guidelines
for atherosclerotic occlusive disease of the lower extremities:
management of asymptomatic disease and claudication.
Journal of Vascular Surgery 2015;61(3 Suppl):2S-41S. [PMID:
25638515]
DerSimonian 1986
DerSimonian R, Laird N. Meta-analysis in clinical trials.
Controlled Clinical Trials 1986;7(3):177-88. [PMID: 3802833]
Dumville 2004
Dumville JC, Lee AJ, Smith FB, Fowkes FG. The health-related
quality of life of people with peripheral arterial disease in the
community: the Edinburgh Artery Study. British Journal of
General Practice 2004;54(508):826-31. [PMID: 15527608]
Fakhry 2018
Fakhry F, Fokkenrood HJ, Spronk S, Teijink JA, Rouwet EV,
Hunink MGM. Endovascular revascularisation versus
conservative management for intermittent claudication.
Cochrane Database of Systematic Reviews 2018, Issue 3. Art. No:
CD010512. [DOI: 10.1002/14651858.CD010512.pub2]
Fokkenrood 2015
Fokkenrood HJ, Lauret GJ, Verhofstad N, Bendermacher BL,
Scheltinga MR, Teijink JA. The eMect of supervised exercise
therapy on physical activity and ambulatory activities in
patients with intermittent claudication. European Journal of
Vascular and Endovascular Surgery 2015;49(2):184-91. [PMID:
25496986]
Fowkes 2013
Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO,
McDermott MM, et al. Comparison of global estimates of
prevalence and risk factors for peripheral artery disease in 2000
and 2010: a systematic review and analysis. Lancet (London,
England) 2013;382(9901):1329-40. [PMID: 23915883]
Gerhard-Herman 2017
Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR,
Corriere MA, Drachman DE, et al. 2016 AHA/ACC Guideline on
the management of patients with lower extremity peripheral
Modes of exercise training for intermittent claudication (Review)









Cochrane Database of Systematic Reviews
artery disease: executive summary: a report of the American
College of Cardiology/American Heart Association Task Force on
Clinical Practice Guidelines. Circulation 2017;135(12):e686-725.
[PMID: 27840332]
Golledge 2018
Golledge J, Maarij K, Moxon JV, Beard JD, Girold S, Wrang H,
et al. Systematic review and meta-analysis of clinical trials
examining the benefit of exercise programmes using Nordic
walking in patients with peripheral artery disease. European
Journal of Vascular Endovascular Surgery 2018;56(4):534-43.
Gommans 2015
Gommans LN, Fokkenrood HJ, Van Dalen HC, Scheltinga MR,
Teijink JA, Peters RJ. Safety of supervised exercise therapy in
patients with intermittent claudication. Journal of Vascular
Surgery 2015;61(2):512-8.e2. [PMID: 25441008]
Gommans 2016
Gommans LN, Hageman D, Jansen I, De Gee R, Van Lummel RC,
Verhofstad N, et al. Minimal correlation between physical
exercise capacity and daily activity in patients with intermittent
claudication. Journal of Vascular Surgery 2016;63(4):983-9.
[PMID: 26806522]
GRADEproGDT 2015 [Computer program]
McMaster University (developed by Evidence Prime)
GRADEproGDT. Version version accessed 15 November 2019.
Hamilton (ON): McMaster University (developed by Evidence
Prime), 2015. Available from www.gradepro.org.
Haas 2012
Haas TL, Lloyd PG, Yang HT, Terjung RL. Exercise training
and peripheral arterial disease. Comprehensive Physiology
2012;2(4):2933-3017. [PMID: 23720270]
Hageman 2018
Hageman D, Fokkenrood HJ, Gommans LN, Van den
Houten MM, Teijink JA. Supervised exercise therapy
versus home-based exercise therapy versus walking
advice for intermittent claudication. Cochrane Database of
Systematic Reviews 2018, Issue 4. Art. No: CD005263. [DOI:
10.1002/14651858.CD005263.pub4]
Harwood 2016
Harwood AE, Cayton T, Sarvanandan R, Lane R, Chetter I. A
review of the potential local mechanisms by which exercise
improves functional outcomes in intermittent claudication.
Annals of Vascular Surgery 2016;30:312-20. [PMID: 26362620]
Higgins 2019
Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ,
Welch VA (editors). Cochrane Handbook for Systematic Reviews
of Interventions Version 6.0 (updated July 2019). Cochrane,
2019. Available from www.training.cochrane.org/handbook.
Jansen 2019
Jansen SCP, Hoorweg BBN, Hoeks SE, Van den Houten MML,
Scheltinga MRM, Teijink JAW, et al. A systematic review
and meta-analysis of the eMects of supervised exercise
therapy on modifiable cardiovascular risk factors in
intermittent claudication. Journal of Vascular Surgery
2019;69(4):1293-1308.e2. [PMID: 30777692]
Kruidenier 2009
Kruidenier LM, Nicolai SP, Hendriks EJ, Bollen EC, Prins MH,
Teijink JA. Supervised exercise therapy for intermittent
claudication in daily practice. Journal of Vascular Surgery
2009;49(2):363-70. [PMID: 19028059]
Lane 2017
Lane R, Harwood A, Watson L, Leng GC. Exercise for
intermittent claudication. Cochrane Database of
Systematic Reviews 2017, Issue 12. Art. No: CD000990. [DOI:
10.1002/14651858.CD000990.pub4]
Lefebvre 2011
Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for
studies. In: Higgins JP, Green S editor(s). Cochrane Handbook
for Systematic Reviews of Interventions Version 5.1.0 (updated
March 2011). The Cochrane Collaboration, 2011. Available from
handbook.cochrane.org.
McDermott 2001
McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH,
Dolan NC, et al. Leg symptoms in peripheral arterial
disease: associated clinical characteristics and functional
impairment. Journal of the American Medical Association
2001;286(13):1599-606. [PMID: 11585483]
Nicolaï 2010
Nicolaï SP, Teijink JA, Prins MH, Exercise Therapy in Peripheral
Arterial Disease Study Group. Multicenter randomized clinical
trial of supervised exercise therapy with or without feedback
versus walking advice for intermittent claudication. Journal of
Vascular Surgery 2010;52(2):348-55. [PMID: 20478681]
Parmenter 2011
Parmenter BJ, Raymond J, Dinnen P, Singh MA. A systematic
review of randomized controlled trials: walking versus
alternative exercise prescription as treatment for intermittent
claudication. Atherosclerosis 2011;218(1):1-12. [PMID: 21601857]
Parmenter 2013b
Parmenter BJ, Raymond J, Fiatarone Singh MA. The eMect of
exercise on fitness and performance-based tests of function in
intermittent claudication: a systematic review. Sports Medicine
(Auckland, NZ) 2013;43(6):513-24. [PMID: 23539309]
Parmenter 2015
Parmenter BJ. Exercise training for management of peripheral
arterial disease: a systematic review and meta-analysis. Sports
Medicine 2015;45(2):231-44.
Piercy 2018
Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton JE,
Galuska DA, et al. The Physical Activity Guidelines for
Americans. JAMA 2018;320(19):2020-8. [PMID: 30418471]
Review Manager 2020 [Computer program]
The Cochrane Collaboration Review Manager 5 (RevMan 5).
Version 5.4. Copenhagen: The Cochrane Collaboration, 2020.
Modes of exercise training for intermittent claudication (Review)









Cochrane Database of Systematic Reviews
Tompra 2015
Tompra N, Foster C, Sanchis-Gomar F, De Koning JJ, Lucia A,
Emanuele E. Upper versus lower limb exercise training in
patients with intermittent claudication: a systematic review.
Atherosclerosis 2015;239(2):599-606.
Treat-Jacobson 2019
Treat-Jacobson D, McDermott MM, Bronas UG, Campia U,
Collins TC, Criqui MH, et al. Optimal exercise programs
for patients with peripheral artery disease: a scientific
statement from the American Heart Association. Circulation
2019;139(4):e10-33. [PMID: 30586765]
 
References to other published versions of this review
Lauret 2012
Lauret GJ, Fakhry F, Fokkenrood HJP, Hunink MG, Teijink JAW,
Spronk S. Modes of exercise training for intermittent
claudication. Cochrane Database of Systematic Reviews 2012,
Issue 2. Art. No: CD009638. [DOI: 10.1002/14651858.CD009638]
Lauret 2014
Lauret GJ, Fakhry F, Fokkenrood HJP, Hunink MGM,
Teijink JAW, Spronk S. Modes of exercise training
for intermittent claudication. Cochrane Database of
Systematic Reviews 2014, Issue 7. Art. No: CD009638. [DOI:
10.1002/14651858.CD009638.pub2]
 
* Indicates the major publication for the study
 
C H A R A C T E R I S T I C S   O F   S T U D I E S




Participants The number of eligible patients was not described, 70 participants were randomised and 52 partici-
pants completed follow-up (4 drop-outs in group 1 and 14 in group 2)
Interventions Group 1: 12 weeks of supervised treadmill exercise
Group 2: 12 weeks of supervised Nordic walking




Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
High risk Pseudorandomisation method was used in which recruited participants were
allocated by the investigators using a fixed block size.
Allocation concealment
(selection bias)
High risk Pseudorandomisation method was used in which recruited participants were





Low risk In all of the included studies, participants and direct personnel could not be
blinded to the intervention (exercise). For this reason, bias could be intro-
duced. However, since all studies experienced the same limitation, we consid-
ered the risk of bias to be low for all studies.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Unclear risk No information provided
Incomplete outcome data
(attrition bias)
High risk The authors reported 18 drop-outs (4 in group 1 and 14 in group 2), without
providing clear reasons (''The main reasons for dropouts from the training pro-
Bulinska 2016 
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All outcomes grammes were personal problems and health disturbances''). The risk of bias
was considered high as the number of drop-outs was high and not evenly dis-
tributed, and no intention-to-treat analysis was performed.
Selective reporting (re-
porting bias)
Low risk All relevant outcomes were described in the study results.
Other bias Unclear risk Significant differences in baseline characteristics were reported for hyperten-
sion and degenerative changes of spine and peripheral joints. These character-






Participants 2296 potential participants were screened for eligibility, 146 were enrolled and 103 were randomised.
The authors reported 18 drop-outs in group 1 and 13 in group 2.
Interventions Group 1: 24 weeks of supervised treadmill exercise
Group 2: 24 weeks of supervised Nordic walking
Outcomes Onset of claudication time, maximum walking time, SF-36 (physical function subscale), WIQ (distance
subscale) and tissue oxygenation measured using near-infrared spectroscopy
Notes -
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomisation was performed with computer-generated permuted blocks.
Allocation concealment
(selection bias)





Low risk In all of the included studies, participants and direct personnel could not be
blinded to the intervention (exercise). For this reason, bias could be intro-
duced. However, since all studies experienced the same limitation, we consid-
ered the risk of bias to be low for all studies.
Blinding of outcome as-
sessment (detection bias)
All outcomes




Unclear risk The authors reported 18 drop-outs in group 1 and 13 drop-outs in group 2.
The reasons were compliance (10), cardiac (9), peripheral vascular surgery (3),
death (1), other medical (7), and moved (1). Although plausible reasons were
provided and intention-to-treat analysis was performed, the risk of bias was
considered unclear as the number of drop-outs was high and not evenly dis-
tributed among groups.
Collins 2012 
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Selective reporting (re-
porting bias)
Low risk All relevant outcomes were described in the study results.
Other bias Low risk No significant differences in baseline characteristics were found. We identified






Participants 111 potential participants assessed for eligibility, 35 participants were randomised (18 in group 1 and
17 in group 2). The authors reported 3 drop-outs in group 1 and 5 in group 2.
Interventions Group 1: 12 weeks of supervised treadmill exercise
Group 2: 12 weeks of combination training (supervised treadmill exercise and resistance training)
Outcomes Australian Vascular QoLIndex, 6-minute walking test, and endothelial function
Notes -
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomisation was performed by computer-based random number genera-
tion using a 1:1 allocation ratio for block sizes which represented the number
of participants recruited within each 3-month interval.
Allocation concealment
(selection bias)






Low risk In all of the included studies, participants and direct personnel could not be
blinded to the intervention (exercise). For this reason, bias could be intro-
duced. However, since all studies experienced the same limitation, we consid-
ered the risk of bias to be low for all studies.
Blinding of outcome as-
sessment (detection bias)
All outcomes




Low risk The authors reported 8 drop-outs: 3 in group 1 due to MI (1), sepsis (1), and lost
of interest (1); and 5 in group 2 due to transient ischaemic attack (2), disc pro-
lapse (1), diabetic foot sepsis (1), and lost of interest (1). ITT analysis and per-
protocol analysis were performed.
Selective reporting (re-
porting bias)
Low risk All relevant outcomes were described in the study results.
Other bias Unclear risk Participants with radiographic aortic-iliac disease were excluded from the
study, but there is no scientific evidence that confirms a difference in treat-
ment effects of exercise related to the level of disease. No significant differ-
Delaney 2015 
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Participants 219 potentially eligible patients, 144 qualified according to criteria, 95 participants were randomised.
The authors reported 15 drop-outs (1 in group 1, 11 in group 2, 3 in group 3), which were excluded from
analysis.
Interventions Group 1: 12 weeks of supervised treadmill exercise
Group 2: 12 weeks of supervised Nordic walking
Group 3: 12 weeks of supervised combination training (resistance training and Nordic walking)
Outcomes Initial claudication distance, maximum claudication distance, 6-minute walking test, force-velocity pa-
rameters of flexor and extensor muscles in the knee and ankle joints
Notes We contacted the authors and received relevant outcome data, which were not clearly described in the
paper.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
High risk Pseudorandomisation method was used in which recruited participants were
allocated by the investigators using a fixed block size.
Allocation concealment
(selection bias)
High risk Pseudorandomisation method was used in which recruited participants were





Low risk In all of the included studies, participants and direct personnel could not be
blinded to the intervention (exercise). For this reason, bias could be intro-
duced. However, since all studies experienced the same limitation, we consid-
ered the risk of bias to be low for all studies.
Blinding of outcome as-
sessment (detection bias)
All outcomes




High risk 18 participants dropped out after randomisation: 1 in the treadmill group
due to deterioration of health and 11 in the Nordic walking group due to dis-
tance between place of residence and place of training (6), health concerns for
undertaking outdoor training (4), and malaise (1); and 3 in the combination
group due to insufficient participation in exercise training (2) and unwilling-
ness to participate in final tests (1). Drop-outs were not evenly distributed and
for 10 participants in group 2 the reasons were related to the intervention it-
self. All drop-outs were excluded from analysis; no intention-to-treat analysis
was performed.
Kropielnicka 2018 
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Selective reporting (re-
porting bias)
Low risk Relevant outcome data for this review (initial claudication distance and maxi-
mal walking distance) were only presented in a figure; no numerical data were
given. However, after contacting the authors, we collected these data.
Other bias Unclear risk The presented baseline characteristics were very limited. We identified no oth-






Participants 1009 participants with asymptomatic and symptomatic PAD were assessed for eligibility; 156 partici-
pants were randomised; after contacting authors, 33 randomised participants were affected by IC.
Interventions Group 1: 24 weeks of supervised treadmill walking
Group 2: 24 weeks of supervised lower-extremity resistance training
Group 3 (control group): 11 nutritional information sessions over 6 months
Outcomes 6-minute walk test, short physical performance battery, brachial artery flow-mediated dilation, physi-
cal activity (accelerometry), maximum treadmill walking time, treadmill time to onset of leg symptoms,
SF-36 physical functioning score, WIQ, knee extension isometric strength/power, plantar flexion iso-
metric strength
Notes We contacted the authors for more information regarding study results for the subgroup of participants
with intermittent claudication.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Participants were randomised by computer using a randomly permuted block










Low risk In all of the included studies, participants and direct personnel could not be
blinded to the intervention (exercise). For this reason, bias could be intro-
duced. However, since all studies experienced the same limitation, we consid-
ered the risk of bias to be low for all studies.
Blinding of outcome as-
sessment (detection bias)
All outcomes




Unclear risk ITT analyses were performed for drop-outs. Analyses were repeated using
multiple imputation for persons who died or dropped out before complet-
ing 6-month follow-up testing. However, because of the study setting, it was
not clear which participants with IC (instead of asymptomatic PAD) dropped
out. The paper stated that missing data at follow-up were more common in
more frail participants. On the other hand, the authors performed a sensitivity
McDermott 2009 
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Low risk All relevant outcomes were described. Although not all secondary outcomes
were mentioned in the trial registration, all outcomes mentioned in the study
protocol were reported in the final draJ of the paper.
Other bias Unclear risk Because of the study setting (the study included participants with asympto-
matic or symptomatic PAD), the baseline characteristics of the subgroup of






Participants 44 participants evaluated: 15 were excluded before randomisation; 29 participants were enrolled and
randomised.
Interventions Group 1: 12 weeks of supervised walking exercise. Secondly, 12 weeks of additional supervised walking
exercise
Group 2: 12 weeks of strength training. Secondly, 12 weeks of additional supervised walking exercise
Group 3 (control group): no treatment for 12 weeks. Secondly, 12 weeks of a combination of supervised
walking exercise and strength training
Outcomes Peak treadmill walking time, ABI (in rest and after exercise), WIQ score, Physical Activity Recall score,
Medical Outcomes Study Questionnaire score, Vitalog activity monitor
Notes -
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk No information provided
Allocation concealment
(selection bias)





Low risk In all of the included studies, participants and direct personnel could not be
blinded to the intervention (exercise). For this reason, bias could be intro-
duced. However, since all studies experienced the same limitation, we consid-
ered the risk of bias to be low for all studies.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Unclear risk To minimise the potential for bias in the self-evaluation of walking ability and
functional status, questionnaires were administered before the treadmill
test. Thus, participants' questionnaire responses were not influenced by their
treadmill exercise performance. In addition, the interviewer and participant
were blinded to previous questionnaire scores.
The paper did not describe whether examiners were blinded to participant
group assignment.
Regensteiner 1996 
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Low risk Two participants in the control group were not available for follow-up at the
12-week evaluation. They were excluded from further analysis. In the super-




Low risk All relevant outcomes were described in the study results.
Other bias Low risk No significant differences in baseline characteristics were found. We identified






Participants 34 participants were randomised; 4 participants did not complete training; 30 participants completed
the study protocol (15 per group).
Interventions Group 1: 12 weeks of supervised treadmill exercise
Group 2: 12 weeks of strength training
Outcomes Initial claudication distance, total walking distance, peak VO2, VO2 at the first stage of treadmill test, is-
chaemic window, leg strength with lower ABI, leg strength with higher ABI
Notes No ITT analysis
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomisation was performed by computer random number generation.
Allocation concealment
(selection bias)





Low risk In all of the included studies, participants and direct personnel could not be
blinded to the intervention (exercise). For this reason, bias could be intro-
duced. However, since all studies experienced the same limitation, we consid-
ered the risk of bias to be low for all studies.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Participants were evaluated at baseline (pre-training) and after 12 weeks of ex-
ercise training (post-training) by a physician who was blinded to the exercise




Low risk 4 participants (2 in the strength training groups and 2 in the walking exercise
groups) did not complete the training programmes for the following reasons:
inguinal hernia (n = 1), gastrointestinal infection (n =1), ongoing treatment for
lung cancer (n = 1), and diagnosis of abdominal aneurysm (n = 1).
Although no ITT analysis was performed, reasons for missing data were plausi-
ble and well distributed among intervention groups.
Ritta-Dias 2010 
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Selective reporting (re-
porting bias)
Low risk All relevant outcomes were described in the study results.
Other bias Low risk No significant differences in baseline characteristics were found. We identified






Participants 694 participants were assessed for eligibility; 43 participants were randomised.
Interventions Group 1: 6 weeks of supervised treadmill exercise
Group 2: 6 weeks of supervised cycling
Group 3 (control group): cardiovascular risk management and exercise advice
Outcomes Maximum walking time, pain-free walking time, maximum cycling time, pain-free cycling time, submax-
imal and peak heart rate/VO2/respiratory exchange ratio/minute ventilation
Notes We contacted the authors and received relevant outcome data, which were not clearly described in the
paper.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk A closed-envelope system was used to randomise participants from the strat-









Low risk In all of the included studies, participants and direct personnel could not be
blinded to the intervention (exercise). For this reason, bias could be intro-
duced. However, since all studies experienced the same limitation, we consid-
ered the risk of bias to be low for all studies.
Blinding of outcome as-
sessment (detection bias)
All outcomes




Low risk One participant in the treadmill training group withdrew after 1 week of train-
ing. The baseline data have been omitted.
Selective reporting (re-
porting bias)
Low risk Relevant outcome data for this review (maximum and pain-free walking time)
were only presented in a figure; no numerical data were given. However, after
contacting the authors, we collected these data.
Other bias Low risk No significant differences in baseline characteristics were found. We identified
no other forms of bias.
Sanderson 2006 
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Participants 50 participants were randomised; the number of eligible patients and the number of participants that
completed follow-up were not provided.
Interventions Group 1: 12 weeks of supervised treadmill exercise
Group 2: 12 weeks of lower limbs resistance training
Outcomes Initial claudication distance, absolute claudication distance, 6-minute walking test, ABI
Notes -
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk ''Patients were randomly assigned''. No further information provided
Allocation concealment
(selection bias)





Low risk In all of the included studies, participants and direct personnel could not be
blinded to the intervention (exercise). For this reason, bias could be intro-
duced. However, since all studies experienced the same limitation, we consid-
ered the risk of bias to be low for all studies.
Blinding of outcome as-
sessment (detection bias)
All outcomes




Unclear risk The text did not specify the number of eligible participants or the number of
participants that completed follow-up. There was no information about drop-
outs or types of analysis (ITT or per-protocol).
Selective reporting (re-
porting bias)
Low risk All relevant outcomes were described in the study results.
Other bias Unclear risk The baseline characteristics were not clearly presented. According to the text
there was a significant difference for baseline ABI between groups. We identi-






Participants 102 participants were assessed for eligibility; 45 participants were randomised.
Interventions Group 1: 12 weeks of arm ergometry
Treat-Jacobson 2009 
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Group 2: 12 weeks of supervised treadmill walking
Group 3: 12 weeks of a combination of arm ergometry and supervised treadmill walking
Group 4 (control group): usual care (cardiovascular management and exercise advice)
Outcomes MWD, pain-free walking distance, resting ABI/heart rate/blood pressure, functional capacity (peak VO2)
Notes The study paper mentioned only the change in walking distances. We were not able to retrieve the ab-
solute values at follow-up for the walking distances through contact with the authors.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Eligible participants were randomised by simple randomisation tables to 1 of
the 4 study groups.
Allocation concealment
(selection bias)





Low risk In all of the included studies, participants and direct personnel could not be
blinded to the intervention (exercise). For this reason, bias could be intro-
duced. However, since all studies experienced the same limitation, we consid-
ered the risk of bias to be low for all studies.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk The physician supervising the treadmill tests was blinded to treatment group
assignment. However, other staM assisting with testing were not blinded. To





Low risk Incomplete outcome data are well described and equally distributed among
intervention groups. 4 of the 45 participants withdrew from the study before
completing exercise training (2 participants in the arm-ergometry group and
2 participants in the treadmill walking group). Therefore, only 41 participants




Low risk All relevant outcomes were described in the study results.
Other bias Low risk No significant differences in baseline characteristics were found. We identified
no other forms of bias.
Treat-Jacobson 2009  (Continued)




MWD: maximal walking distance
PAD: peripheral arterial disease
PFWD: pain-free walking distance
QoL: quality of life
RCT: randomised controlled trial
SET: supervised exercise therapy
SF-36: 36-item Short Form Health Survey
SMM: skeletal muscle mass
VO2: pulmonary oxygen uptake
WIQ: Walking Impairment Questionnaire
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Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Dedes 2010 Meeting poster; no journal article available
Delaney 2014 No correct outcome measures
EXERT Study 2018 The original results of the EXERT study are not published. Only one publication is available com-
paring long-term follow-up (1 to 4 years) to end of study results (24 weeks). Baseline data were not
available from the authors.
Gardner 2011 Commentary on other journal article; not an RCT
Jones 1996 Outcome measures unclearly described; no information from authors
Kao 2012 Meeting poster; no article available (authors contacted)
Kim 2006 Commentary on other journal article; not an RCT
Kuwabara 2010 Meeting poster; no article available
Nawaz 2001 No intervention group with adequate supervised walking therapy; no correct outcome measures
Oakley 2008 No intervention group with adequate supervised walking therapy
Ornelas 2011 Meeting poster; no article available
Parmenter 2013 No control group with SET
Parr 2009 No intervention group with adequate supervised walking therapy
Roitman 2010 Editorial; not an RCT
Saxton 2008 No control group with adequate SET; no correct outcome measures
Saxton 2011 No control group with adequate SET; no correct outcome measures (MWD assessed by shuttle-walk
test instead of protocolised treadmill test)
Tebbutt 2011 No control group with adequate SET
Treat-Jacobson 2011 No relevant outcome measures for this review assessed and reported
Treat-Jacobson 2012 Meeting poster; no journal article available; no control group with adequate SET
Van Schaardenburgh 2017 No control group with adequate SET
Walker 2000 No control group with adequate SET; no correct outcome measures (no treadmill test)
Wang 2008 No control group with SET
Zwierska 2005 No control group with adequate SET
MWD: maximum walking distance
RCT: randomised controlled trial
SET: supervised exercise therapy
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Characteristics of ongoing studies [ordered by study ID]
 
Study name Comparison of the effects of supervised treadmill walking training and supervised walking with
poles on the functional capabilities, the function of endothelium and the metabolic cost of walking
in patients with IC
Methods Study type: interventional
Study design: RCT
Masking: open (no masking used)
Primary purpose: treatment
Participants Recruitment status: completed
Number of participants: 90
Inclusion criteria:
• Age: older than 50 years;
• Patients with atherosclerosis of lower extremities evaluated according to the Fontaine's classifi-
cation as degree IIA and IIB;
• ABI < 0.9;
• No systemic contraindications to undertake the proposed forms of exercise;
• Written consent to participate in a clinical trial.
Exclusion criteria:
• Inability to walk on a treadmill at a speed of 2 mph;
• Recently completed vascular treatments (less than 6 months);
• Changes in pharmacological treatment (less than 6 months);
• Symptomatic coronary artery disease, exertional dyspnoea, resting blood pressure higher than
160/100 mmHg, resting tachycardia higher than 100/min, thrombophlebitis, arterial embolism,
active cancer, exercise-induced asthma, cardiorespiratory failure (NYHA III)
Interventions There are three study arms:
• 12 weeks of supervised treadmill walking three times a week
• 12 weeks of supervised walking with poles three times a week
• A control group that will be instructed according to standard preventive recommendation and
will not undergo walking training
Outcomes All outcomes will be measured at baseline and after 12 weeks
Primary outcome measures:
• MWD (treadmill test, Gardner protocol)
• Vascular endothelial function (flow mediated dilatation)
• Metabolic cost of walking determined using oxygen consumption measure (graded treadmill
walking test with simultaneous breath-by-breath VO2 measurements)
Secondary outcomes measures:
• PFWD (treadmill test, Gardner protocol)
• Functional walking ability (WIQ)
Starting date Date of first participant enrolment: April 2016
ACTRN12616000243415 
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Date of last participant enrolment: March 2018
Date of last data collection: June 2018
Contact information Miss Ewelina Rosloniec
Akademia Wychowania Fizycznego w Krakowie
Zawodzie 1a/18, 31-232 Krakow, Poland





Study name Effects of arm-crank exercise training on cardiovascular function of patients with PAD: an RCT
Methods Study type: interventional
Study design: RCT; parallel assignment
Masking: double (investigator, outcome assessor)
Primary purpose: treatment
Participants Estimated enrolment: 45 participants
Inclusion criteria:
• Age 45 to 85 years
• PAD stage II
• ABI < 0.90 in one or both lower limbs
• Women in postmenopause phase without hormone replacement therapy
• Not an active smoker
• Able to perform exercise training
Exclusion criteria:
• PAD stage I, III and IV
• Presence of diabetic neuropathy
Interventions There are three study arms:
• 12 weeks of supervised arm-crank exercise twice a week
• 12 weeks of supervised treadmill walking twice a week
• 12 weeks of active control sessions twice a week (patients will perform manual tasks without ex-
ercise component)
Outcomes All outcomes will be measured at baseline and after 12 weeks
Primary outcome measure:
• Ambulatory blood pressure (systolic, diastolic and mean blood pressure)
Secondary outcome measures:
• Clinical blood pressure (systolic and diastolic blood pressure)
• Cardiac autonomic modulation (heart rate monitor)
• Arterial stiffness (pulse wave velocity)
NCT03837639 
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• Vasodilatory capacity (flow mediated dilation)
Other measures (additional information on request, not described in trial registry):
• 6-minute walking test
• Functional capacity (2 questionnaires: Walking Estimated-Limitation Calculated by History
(WELCH) and WIQ)
Starting date Estimated starting date: April 2019
Contact information Gabriel Cucato, PhD
Hospital Israelita Albert Einstein, São Paulo, Brazil, 05652-900
Notes We contacted Dr Cucato to confirm that functional tests will be performed.
NCT03837639  (Continued)
ABI: ankle brachial index
IC: intermittent claudication
mph: miles per hour
MWD: maximal walking distance
PAD: peripheral arterial disease
PFWD: pain-free walking distance
RCT: randomised controlled trial
WELCH: walking estimated-limitation calculated by history
WIQ: walking impairment questionnaire
 
 
D A T A   A N D   A N A L Y S E S
 
Comparison 1.   Alternative modes of exercise versus walking exercise at 12 weeks





Statistical method Effect size
1.1 Maximum walking distance 6 274 Std. Mean Difference (IV, Random, 95% CI) -0.01 [-0.29, 0.27]
1.1.1 Lower-extremity resistance
training
3 94 Std. Mean Difference (IV, Random, 95% CI) -0.02 [-0.59, 0.55]
1.1.2 Nordic walking 2 88 Std. Mean Difference (IV, Random, 95% CI) 0.31 [-0.12, 0.74]
1.1.3 Combined exercise modes 3 74 Std. Mean Difference (IV, Random, 95% CI) -0.19 [-0.66, 0.29]
1.1.4 Arm ergometry 1 18 Std. Mean Difference (IV, Random, 95% CI) -0.84 [-1.87, 0.19]
1.2 Pain-free walking distance 5 249 Std. Mean Difference (IV, Random, 95% CI) -0.01 [-0.26, 0.25]
1.2.1 Lower-extremity resistance
training
2 80 Std. Mean Difference (IV, Random, 95% CI) 0.11 [-0.32, 0.55]
1.2.2 Nordic walking 2 88 Std. Mean Difference (IV, Random, 95% CI) 0.14 [-0.28, 0.57]
1.2.3 Combined exercise modes 2 63 Std. Mean Difference (IV, Random, 95% CI) -0.22 [-0.74, 0.30]
1.2.4 Arm ergometry 1 18 Std. Mean Difference (IV, Random, 95% CI) -0.65 [-1.66, 0.36]
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Analysis 1.1.   Comparison 1: Alternative modes of exercise versus
walking exercise at 12 weeks, Outcome 1: Maximum walking distance
Study or Subgroup





Heterogeneity: Tau² = 0.10; Chi² = 3.33, df = 2 (P = 0.19); I² = 40%





Heterogeneity: Tau² = 0.00; Chi² = 0.00, df = 1 (P = 0.95); I² = 0%
Test for overall effect: Z = 1.43 (P = 0.15)





Heterogeneity: Tau² = 0.00; Chi² = 1.24, df = 2 (P = 0.54); I² = 0%





Test for overall effect: Z = 1.60 (P = 0.11)
Total (95% CI)
Heterogeneity: Tau² = 0.03; Chi² = 9.81, df = 8 (P = 0.28); I² = 18%
Test for overall effect: Z = 0.06 (P = 0.95)

























































































IV, Random, 95% CI
-0.97 [-2.14 , 0.20]
0.17 [-0.55 , 0.89]
0.21 [-0.35 , 0.77]
-0.02 [-0.59 , 0.55]
0.32 [-0.23 , 0.88]
0.30 [-0.37 , 0.96]
0.31 [-0.12 , 0.74]
0.03 [-0.59 , 0.64]
-0.40 [-1.61 , 0.80]
-0.58 [-1.53 , 0.38]
-0.19 [-0.66 , 0.29]
-0.84 [-1.87 , 0.19]
-0.84 [-1.87 , 0.19]
-0.01 [-0.29 , 0.27]
Std. Mean Difference
IV, Random, 95% CI
-2 -1 0 1 2
Favours walking Favours alternative modes
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Analysis 1.2.   Comparison 1: Alternative modes of exercise versus
walking exercise at 12 weeks, Outcome 2: Pain-free walking distance
Study or Subgroup




Heterogeneity: Tau² = 0.00; Chi² = 0.00, df = 1 (P = 0.95); I² = 0%





Heterogeneity: Tau² = 0.00; Chi² = 0.00, df = 1 (P = 0.97); I² = 0%
Test for overall effect: Z = 0.66 (P = 0.51)




Heterogeneity: Tau² = 0.00; Chi² = 0.29, df = 1 (P = 0.59); I² = 0%





Test for overall effect: Z = 1.26 (P = 0.21)
Total (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 3.28, df = 6 (P = 0.77); I² = 0%
Test for overall effect: Z = 0.04 (P = 0.97)











































































IV, Random, 95% CI
0.13 [-0.58 , 0.85]
0.10 [-0.45 , 0.66]
0.11 [-0.32 , 0.55]
0.15 [-0.40 , 0.70]
0.13 [-0.53 , 0.80]
0.14 [-0.28 , 0.57]
-0.13 [-0.74 , 0.49]
-0.44 [-1.38 , 0.51]
-0.22 [-0.74 , 0.30]
-0.65 [-1.66 , 0.36]
-0.65 [-1.66 , 0.36]
-0.01 [-0.26 , 0.25]
Std. Mean Difference
IV, Random, 95% CI
-2 -1 0 1 2
Favours walking Favours alternative modes
 
 
Comparison 2.   Alternative modes of exercise versus walking exercise at the end of training





Statistical method Effect size





4 127 Std. Mean Difference (IV, Random, 95%
CI)
-0.06 [-0.48, 0.35]
2.1.2 Nordic walking 3 165 Std. Mean Difference (IV, Random, 95%
CI)
0.04 [-0.47, 0.54]
2.1.3 Combined exercise modes 3 74 Std. Mean Difference (IV, Random, 95%
CI)
-0.19 [-0.66, 0.29]
2.1.4 Arm ergometry 1 18 Std. Mean Difference (IV, Random, 95%
CI)
-0.84 [-1.87, 0.19]
2.1.5 Cycling 1 28 Std. Mean Difference (IV, Random, 95%
CI)
-0.31 [-1.06, 0.43]
2.2 Pain-free walking distance 8 382 Std. Mean Difference (IV, Random, 95%
CI)
-0.06 [-0.30, 0.17]
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Statistical method Effect size
2.2.1 Lower-extremity resistance
training
3 108 Std. Mean Difference (IV, Random, 95%
CI)
0.01 [-0.37, 0.38]
2.2.2 Nordic walking 3 165 Std. Mean Difference (IV, Random, 95%
CI)
0.21 [-0.10, 0.52]
2.2.3 Combined exercise modes 2 63 Std. Mean Difference (IV, Random, 95%
CI)
-0.22 [-0.74, 0.30]
2.2.4 Arm ergometry 1 18 Std. Mean Difference (IV, Random, 95%
CI)
-0.65 [-1.66, 0.36]
2.2.5 Cycling 1 28 Std. Mean Difference (IV, Random, 95%
CI)
-1.01 [-1.81, -0.22]
2.3 Functional impairment (WIQ
distance score)
2 96 Mean Difference (IV, Random, 95% CI) -5.52 [-17.41, 6.36]
2.3.1 Lower-extremity resistance
training
1 19 Mean Difference (IV, Random, 95% CI) -14.00 [-36.64, 8.64]
2.3.2 Nordic walking 1 77 Mean Difference (IV, Random, 95% CI) -2.30 [-16.26, 11.66]
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Analysis 2.1.   Comparison 2: Alternative modes of exercise versus walking
exercise at the end of training, Outcome 1: Maximum walking distance
Study or Subgroup






Heterogeneity: Tau² = 0.04; Chi² = 3.93, df = 3 (P = 0.27); I² = 24%






Heterogeneity: Tau² = 0.12; Chi² = 4.96, df = 2 (P = 0.08); I² = 60%
Test for overall effect: Z = 0.15 (P = 0.88)





Heterogeneity: Tau² = 0.00; Chi² = 1.24, df = 2 (P = 0.54); I² = 0%










Test for overall effect: Z = 0.82 (P = 0.41)
Total (95% CI)
Heterogeneity: Tau² = 0.02; Chi² = 12.95, df = 11 (P = 0.30); I² = 15%
Test for overall effect: Z = 1.00 (P = 0.32)

















































































































IV, Random, 95% CI
-0.26 [-0.95 , 0.42]
-0.97 [-2.14 , 0.20]
0.17 [-0.55 , 0.89]
0.21 [-0.35 , 0.77]
-0.06 [-0.48 , 0.35]
0.32 [-0.23 , 0.88]
-0.40 [-0.85 , 0.06]
0.30 [-0.37 , 0.96]
0.04 [-0.47 , 0.54]
0.03 [-0.59 , 0.64]
-0.40 [-1.61 , 0.80]
-0.58 [-1.53 , 0.38]
-0.19 [-0.66 , 0.29]
-0.84 [-1.87 , 0.19]
-0.84 [-1.87 , 0.19]
-0.31 [-1.06 , 0.43]
-0.31 [-1.06 , 0.43]
-0.11 [-0.33 , 0.11]
Std. Mean Difference
IV, Random, 95% CI
-2 -1 0 1 2
Favours walking Favours alternative modes
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Analysis 2.2.   Comparison 2: Alternative modes of exercise versus walking
exercise at the end of training, Outcome 2: Pain-free walking distance
Study or Subgroup





Heterogeneity: Tau² = 0.00; Chi² = 0.93, df = 2 (P = 0.63); I² = 0%






Heterogeneity: Tau² = 0.00; Chi² = 0.19, df = 2 (P = 0.91); I² = 0%
Test for overall effect: Z = 1.32 (P = 0.19)




Heterogeneity: Tau² = 0.00; Chi² = 0.29, df = 1 (P = 0.59); I² = 0%










Test for overall effect: Z = 2.49 (P = 0.01)
Total (95% CI)
Heterogeneity: Tau² = 0.03; Chi² = 11.51, df = 9 (P = 0.24); I² = 22%
Test for overall effect: Z = 0.54 (P = 0.59)



































































































IV, Random, 95% CI
-0.31 [-1.06 , 0.44]
0.13 [-0.58 , 0.85]
0.10 [-0.45 , 0.66]
0.01 [-0.37 , 0.38]
0.15 [-0.40 , 0.70]
0.28 [-0.17 , 0.73]
0.13 [-0.53 , 0.80]
0.21 [-0.10 , 0.52]
-0.13 [-0.74 , 0.49]
-0.44 [-1.38 , 0.51]
-0.22 [-0.74 , 0.30]
-0.65 [-1.66 , 0.36]
-0.65 [-1.66 , 0.36]
-1.01 [-1.81 , -0.22]
-1.01 [-1.81 , -0.22]
-0.06 [-0.30 , 0.17]
Std. Mean Difference
IV, Random, 95% CI
-2 -1 0 1 2
Favours walking Favours alternative modes
 
 
Analysis 2.3.   Comparison 2: Alternative modes of exercise versus walking exercise
at the end of training, Outcome 3: Functional impairment (WIQ distance score)
Study or Subgroup









Test for overall effect: Z = 0.32 (P = 0.75)
Total (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.74, df = 1 (P = 0.39); I² = 0%
Test for overall effect: Z = 0.91 (P = 0.36)


































IV, Random, 95% CI
-14.00 [-36.64 , 8.64]
-14.00 [-36.64 , 8.64]
-2.30 [-16.26 , 11.66]
-2.30 [-16.26 , 11.66]
-5.52 [-17.41 , 6.36]
Mean Difference
IV, Random, 95% CI
-100 -50 0 50 100
Favours walking Favours alternative modes
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HR-QOL Health-related quality of life
IC Intermittent claudication
MD Mean difference
MWD Maximum walking distance
PFWD Pain-free walking distance
PAD Peripheral arterial disease
RCT Randomised controlled trial
SD Standard deviation
SMD Standardised mean difference
WIQ Walking impairment questionnaire
   
Definitions  
Arm-ergometry Ergometry is a heart rate increasing activity. In arm-ergometry, an arm ergometer is used (also re-
ferred to as an arm cycle or arm crank), which is an alternative to the treadmill or leg cycle.
Endothelial and mitochondrial
dysfunction
This means that the endothelial cells and mitochondria do not function as well as they should due
to a disease or condition. Endothelial cells form a thin layer that line the interior surface of blood




Flow-mediated dilatation refers to dilatation (widening) of a blood vessel when blood flow increas-
es in that vessel. This process is primarily regulated by endothelial cells, which form a thin layer
that line the interior surface of blood vessels.
Metabolic adaptation This is the process by which the body (e.g. the skeletal muscle) alters how efficient it is at obtaining
energy and this increases capacity.
Pain tolerance Pain tolerance is the maximum level of pain that a person is able to tolerate.
Vascular angiogenesis This is the physiological process through which new blood vessels form from pre-existing vessels.
Table 1.   Glossary of abbreviations and definitions 
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A P P E N D I C E S
Appendix 1. Database search strategies
 
Source Search strategy Hits retrieved
CENTRAL (2013 -
2019)
#1 MESH DESCRIPTOR Arteriosclerosis 948
#2 MESH DESCRIPTOR Arteriolosclerosis EXPLODE ALL TREES 0
#3 MESH DESCRIPTOR Arteriosclerosis Obliterans EXPLODE ALL TREES 81
#4 MESH DESCRIPTOR Atherosclerosis 1092
#5 MESH DESCRIPTOR Arterial Occlusive Diseases 831
#6 MESH DESCRIPTOR Intermittent Claudication EXPLODE ALL TREES 839
#7 MESH DESCRIPTOR Peripheral Vascular Diseases EXPLODE ALL TREES 2835
#8 (atherosclero* or arteriosclero* or PVD or PAOD or PAD):TI,AB,KY 11697
#9 ((arter* or vascular or vein* or veno* or peripher*) adj3 (occlus* or steno* or ob-
struct* or lesio* or block* or harden* or stiffen* or obliter*)):TI,AB,KY 10266
#10 (peripheral adj3 dis*):TI,AB,KY 4857
#11 (claudic* or IC):TI,AB,KY 3745
#12 arteriopathic:TI,AB,KY 7
#13 dysvascular*:TI,AB,KY 23
#14 (leg adj3 (occlus* or steno* or obstruct* or lesio* or block* or harden* or stiffen*
or obliter*)):TI,AB,KY 128
#15 (limb adj3 (occlus* or steno* or obstruct* or lesio* or block* or harden* or stiff-
en* or obliter*)):TI,AB,KY 220
#16 (lower adj3 extrem* adj3 (occlus* or steno* or obstruct* or lesio* or block* or
harden* or stiffen* or obliter*)):TI,AB,KY 93
#17 ((iliac or femoral or popliteal or femoro* or fempop* or crural or tibial)
adj3 (occlus* or steno* or obstruct* or lesio* or block* or harden* or stiffen* or
obliter*)):TI,AB,KY 1499
#18 MESH DESCRIPTOR Iliac Artery EXPLODE ALL TREES 159
#19 MESH DESCRIPTOR Popliteal Artery EXPLODE ALL TREES 314
#20 MESH DESCRIPTOR Femoral Artery EXPLODE ALL TREES 927
#21 MESH DESCRIPTOR Tibial Arteries EXPLODE ALL TREES 40
#22 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR
#13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 29244
#23 MESH DESCRIPTOR Exercise EXPLODE ALL TREES 21271
#24 MESH DESCRIPTOR Dancing 152
#25 MESH DESCRIPTOR Sports EXPLODE ALL TREES 14172
#26 MESH DESCRIPTOR Exercise Therapy EXPLODE ALL TREES 11534
1766
 
Modes of exercise training for intermittent claudication (Review)









Cochrane Database of Systematic Reviews
#27 (physical adj (exercise* or exertion or endurance or therapy or conditioning or
activity or activities or fitness or training)):TI,AB,KY 38005
#28 (exercise adj (training or intervention or programme or therapy or activity or
regime)):TI,AB,KY 22027
#29 (fitness adj (training or intervention or protocol or programme or therapy or ac-
tivity or regime)):TI,AB,KY 1383
#30 ((training or conditioning) adj (circuit or intervention or protocol or programme
or activity or regime)):TI,AB,KY 5603
#31 (walk or walking or run or running or treadmill or aerobic or swim or swimming
or dance or dancing or cycling or cyclist):TI,AB,KY 43589
#32 kinesiotherap*:TI,AB,KY 2187
#33 ((endurance or aerobic or cardio*) adj (fitness or training or intervention or pro-
tocol or program* or therapy or activity or regime)):TI,AB,KY 14421
#34 #23 OR #24 OR #25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33
94718
#35 #22 AND #34 3281
#36 01/01/2013 TO 04/03/2019:CD 629526
#37 #35 AND #36 1766
Clinicaltrials.gov
(2013 - 2019)
Intermittent Claudication OR Peripheral Vascular Diseases OR Peripheral Arterial
Disease OR Arterial Occlusive Diseases | Exercise Therapy OR Exercise OR Resistance
Training OR walking OR dancing OR running OR run OR cycling OR cyclist OR tread-
mill OR aerobic OR kinesiotherap* | Start date on or after 01/01/2013 | Last update




Intermittent Claudication OR Peripheral Vascular Diseases OR Peripheral Arterial
Disease OR Arterial Occlusive Diseases | Exercise Therapy OR Exercise OR Resistance
Training OR walking OR dancing OR running OR run OR cycling OR cyclist OR tread-




Ahead of Print, In-






2 exp Peripheral Vascular Diseases/
3 exp Peripheral Arterial Disease/
4 exp Arterial Occlusive Diseases/





10 (PVD or PAOD or PAD).ti,ab.
11 ((arter* or vascular or vein* or veno* or peripher*) adj3 (occlus* or steno* or ob-
struct* or lesio* or block* or harden* or stiffen* or obliter*)).ti,ab.
12 (peripheral adj3 dis*).ti,ab.
1308
  (Continued)
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16 (leg adj3 (occlus* or steno* or obstruct* or lesio* or block* or harden* or stiffen*
or obliter*)).ti,ab.
17 (limb adj3 (occlus* or steno* or obstruct* or lesio* or block* or harden* or stiffen*
or obliter*)).ti,ab.
18 (lower adj3 extrem*) adj3 (occlus* or steno* or obstruct* or lesio* or block* or
harden* or stiffen* or obliter*)).ti,ab.
19 ((iliac or femoral or popliteal or femoro* or fempop* or crural or tibial) adj3




22 exp Exercise Therapy/
23 exp Resistance Training/
24 exp Walking/
25 Dancing/
26 (physical adj (exercise* or exertion or endurance or therapy or conditioning or ac-
tivity or activities or fitness or training)).ti,ab.
27 (exercise adj (training or intervention or programme or therapy or activity or
regime)).ti,ab.
28 (fitness adj (training or intervention or protocol or programme or therapy or ac-
tivity or regime)).ti,ab.
29 ((training or conditioning) adj (circuit or intervention or protocol or programme
or activity or regime)).ti,ab.
30 (walk or walking or run or running or treadmill or aerobic or swim or swimming
or dance or dancing or cycling or cyclist).ti,ab.
31 kinesiotherap*.ti,ab.
32 ((endurance or aerobic or cardio*) adj (fitness or training or intervention or pro-
tocol or program* or therapy or activity or regime)).ti,ab.
33 or/21-32
34 20 and 33
35 randomized controlled trial.pt.
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44 exp animals/ not humans.sh.
45 43 not 44
46 34 and 45
47 (2013* or 2014* or 2015* or 2016* or 2017* or 2018* or 2019*).ed.
48 46 and 47
Embase (2013 - 2019) 1 Intermittent Claudication/
2 peripheral vascular disease/





8 (PVD or PAOD).ti,ab.
9 ((arter* or vascular or vein* or veno* or peripher*) adj3 (occlus* or steno* or ob-
struct* or lesio* or block* or harden* or stiffen* or obliter*)).ti,ab.




14 (leg adj3 (occlus* or steno* or obstruct* or lesio* or block* or harden* or stiffen*
or obliter*)).ti,ab.
15 (limb adj3 (occlus* or steno* or obstruct* or lesio* or block* or harden* or stiffen*
or obliter*)).ti,ab.
16 (lower adj3 extrem* adj3 (occlus* or steno* or obstruct* or lesio* or block* or
harden* or stiffen* or obliter*)).ti,ab.
17 ((iliac or femoral or popliteal or femoro* or fempop* or crural or tibial) adj3
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24 (physical adj (exercise* or exertion or endurance or therapy or conditioning or ac-
tivity or activities or fitness or training)).ti,ab.
25 (exercise adj (training or intervention or programme or therapy or activity or
regime)).ti,ab.
26 (fitness adj (training or intervention or protocol or programme or therapy or ac-
tivity or regime)).ti,ab.
27 ((training or conditioning) adj (circuit or intervention or protocol or programme
or activity or regime)).ti,ab.
28 (walk or walking or run or running or treadmill or aerobic or swim or swimming
or dance or dancing or cycling or cyclist).ti,ab.
29 kinesiotherap*.ti,ab.
30 ((endurance or aerobic or cardio*) adj (fitness or training or intervention or pro-
tocol or program* or therapy or activity or regime)).ti,ab.
31 or/19-30
32 18 and 31
33 randomized controlled trial/





39 (compare or compared or comparison).ti.
40 ((evaluated or evaluate or evaluating or assessed or assess) and (compare or
compared or comparing or comparison)).ab.
41 (open adj label).ti,ab.
42 ((double or single or doubly or singly) adj (blind or blinded or blindly)).ti,ab.
43 double blind procedure/
44 parallel group$1.ti,ab.
45 (crossover or cross over).ti,ab.
46 ((assign$ or match or matched or allocation) adj5 (alternate or group$1 or inter-
vention$1 or patient$1 or subject$1 or participant$1)).ti,ab.
47 (assigned or allocated).ti,ab.
48 (controlled adj7 (study or design or trial)).ti,ab.
49 (volunteer or volunteers).ti,ab.
50 trial.ti.
51 or/33-50
52 32 and 51
53 (2013* or 2014* or 2015* or 2016* or 2017* or 2018* or 2019*).em.
  (Continued)
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54 52 and 53
CINAHL (2017 - 2019) S50 S48 AND S49
S49 EM 2017 OR EM 2018 OR EM 2019
S48 S34 AND S47
S47 S35 OR S36 OR S37 OR S38 OR S39 OR S40 OR S41 OR S42 OR S43 OR S44 OR S45
OR S46
S46 MH "Random Assignment"
S45 MH "Single-Blind Studies" or MH "Double-Blind Studies" or MH "Triple-Blind
Studies"
S44 MH "Crossover Design"
S43 MH "Factorial Design"
S42 MH "Placebos"
S41 MH "Clinical Trials"
S40 TX "multi-centre study" OR "multi-center study" OR "multicentre study" OR
"multicenter study" OR "multi-site study"




S35 TX "latin square"
S34 S19 AND S33
S33 S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30
OR S31 OR S32
S32 TX (endurance or aerobic or cardio*)N (fitness or training or intervention or pro-
tocol or program* or therapy or activity or regime)
S31 TX kinesiotherap*
S30 TX walk or walking or run or running or treadmill or aerobic or swim or swim-
ming or dance or dancing or cycling or cyclist
S29 TX training or conditioning) N (circuit or intervention or protocol or programme
or activity or regime)
S28 TX fitness N (training or intervention or protocol or programme or therapy or ac-
tivity or regime)
S27 TX exercise N (training or intervention or programme or therapy or activity or
regime)
S26 TX physical N (exercise* or exertion or endurance or therapy or conditioning or
activity or activities or fitness or training))
S25 (MH "Dancing+")
S24 (MH "Nordic Walking")
206
  (Continued)
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S23 (MH "Walking+")
S22 (MH "Resistance Training")
S21 (MH "Therapeutic Exercise+")
S20 (MH "Exercise+")
S19 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR
S13 OR S14 OR S15 OR S16 OR S17 OR S18
S18 TX (iliac or femoral or popliteal or femoro* or fempop* or crural or tibial) N3 (oc-
clus* or steno* or obstruct* or lesio* or block* or harden* or stiffen* or obliter*)
S17 TX (lower N3 extrem*) N3 (occlus* or steno* or obstruct* or lesio* or block* or
harden* or stiffen* or obliter*))
S16 TX limb N3 (occlus* or steno* or obstruct* or lesio* or block* or harden* or stiff-
en* or obliter*)





S11 TX peripheral N3 dis*
S10 TX (arter* or vascular or vein* or veno* or peripher*) N3 (occlus* or steno* or ob-
struct* or lesio* or block* or harden* or stiffen* or obliter*)
S9 TX PVD or PAOD
S8 (MH "Tibial Arteries")
S7 (MH "Femoral Artery")
S6 (MH "Popliteal Artery")
S5 (MH "Iliac Artery")
S4 (MH "Leg/BS")
S3 (MH "Arterial Occlusive Diseases+")
S2 (MH "Peripheral Vascular Diseases+")
S1 (MH "Intermittent Claudication")
AMED (2013 - 2019) 1 exp Intermittent claudication/
2 exp Peripheral vascular disease/
3 exp Arterial occlusive disease/
4 (PVD or PAOD or PAD).ti,ab.
5 ((arter* or vascular or vein* or veno* or peripher*) adj3 (occlus* or steno* or ob-
struct* or lesio* or block* or harden* or stiffen* or obliter*)).ti,ab.
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8 arteriopathic.ti,ab.
9 dysvascular*.ti,ab.
10 (leg adj3 (occlus* or steno* or obstruct* or lesio* or block* or harden* or stiffen*
or obliter*)).ti,ab.
11 (limb adj3 (occlus* or steno* or obstruct* or lesio* or block* or harden* or stiffen*
or obliter*)).ti,ab.
12 (lower adj3 extrem* adj3 (occlus* or steno* or obstruct* or lesio* or block* or
harden* or stiffen* or obliter*)).ti,ab.
13 ((iliac or femoral or popliteal or femoro* or fempop* or crural or tibial) adj3




16 exp Exercise therapy/
17 exp Resistance training/
18 exp Walking/
19 exp Dancing/
20 (physical adj (exercise* or exertion or endurance or therapy or conditioning or ac-
tivity or activities or fitness or training)).ti,ab.
21 (exercise adj (training or intervention or programme or therapy or activity or
regime)).ti,ab.
22 (fitness adj (training or intervention or protocol or programme or therapy or ac-
tivity or regime)).ti,ab.
23 ((training or conditioning) adj (circuit or intervention or protocol or programme
or activity or regime)).ti,ab.
24 (walk or walking or run or running or treadmill or aerobic or swim or swimming
or dance or dancing or cycling or cyclist).ti,ab.
25 kinesiotherap*.ti,ab.
26 ((endurance or aerobic or cardio*) adj (fitness or training or intervention or pro-
tocol or program* or therapy or activity or regime)).ti,ab.
27 or/15-26
28 14 and 27
29 exp CLINICAL TRIALS/
30 RANDOM ALLOCATION/
31 DOUBLE BLIND METHOD/
32 Clinical trial.pt.
33 (clinic* adj trial*).tw.
34 ((singl* or doubl* or trebl* or tripl*) adj (blind* or mask*)).tw.
35 PLACEBOS/
  (Continued)
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40 28 and 39
41 ("2017" or "2018" or "2019").yr.
42 40 and 41
  (Continued)
 
W H A T ' S   N E W
 
Date Event Description
29 October 2019 New citation required but conclusions
have not changed
Searches updated. Five new studies included and two ongoing
studies identified. Six new studies excluded. New authors joined
team. Text updated to reflect current Cochrane standards includ-
ing addition of 'Summary of findings' table. No change to conclu-
sions.
29 October 2019 New search has been performed Searches updated. Five new studies included and two ongoing
studies identified. Six new studies excluded.
 
H I S T O R Y
Protocol first published: Issue 2, 2012
Review first published: Issue 7, 2014
C O N T R I B U T I O N S   O F   A U T H O R S
SJ: updated the protocol, selected relevant studies, assessed study quality, extracted data, performed data analysis, and wrote the text
of this update.
UA: contributed to updating the protocol, selected studies, assessed study quality, extracted data, checked data for accuracy, and
contributed to the text of the review.
GJL: contributed to updating the protocol, confirmed suitability of selected studies for inclusion, was consulted where disagreements
occurred, checked data for accuracy, and revised the text of the review. In the previous version, he wrote the protocol, selected relevant
studies, assessed study quality, extracted data, and wrote the review.
FF: contributed to updating the protocol, confirmed suitability of selected studies for inclusion, and revised the text. In the previous version,
he contributed to the protocol, selected relevant studies, assessed study quality, and extracted data.
HF: contributed to updating the protocol, confirmed suitability of selected studies for inclusion, and revised the text. In the previous version,
he contributed to the protocol and to the text of the review.
JT: contributed to the protocol, confirmed suitability of selected studies for inclusion, and contributed to the text of the review (both in
the updated and previous version of the review).
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S O U R C E S   O F   S U P P O R T
Internal sources
• No sources of support supplied
External sources
• Chief Scientist OMice, Scottish Government Health Directorates, the Scottish Government, UK
Cochrane Vascular's editorial base is supported by the Chief Scientist OMice.
D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W
For this update, in the Types of interventions section, 'Nordic walking' was added as an alternative mode of exercise. In the original protocol
and review, studies comparing diMerent types of walking exercise were not included, and Nordic walking was considered a diMerent type of
walking exercise. Recent publications have led to a diMerent insight, as Nordic walking is diMerent from standard walking because it uses a
core-focused walking technique which engages the muscles of the arms and trunk to reduce the load on the legs during walking. Therefore,
the criterion for not including studies was changed to 'diMerent settings of walking exercise' (supervised versus unsupervised, community-
based versus hospital), and Nordic walking was included as an alternative mode of exercise. In the Data collection and analysis section,
a diMerent method to analyse treatment eMect was used in this update. In the case of diMerent treadmill test protocols, the standardised
mean diMerence approach was used for summary statistics. Therefore, it was no longer necessary to convert times or distances to metabolic
equivalent of tasks (METs).
In the previous version, we altered the primary outcome from mean change in maximum or pain-free walking distance to a post-
intervention maximum or pain-free walking distance. AJer extracting the data, most of the included trials only reported pre-intervention
and post-intervention walking distances and their variances. No data on mean change were reported. Although calculating the mean
change in walking distance from the pre-intervention and post-intervention data was possible, calculating a variance (standard deviation)
of the mean change without having individual participant data was more challenging. To calculate a variance of the mean change from the
reported summary pre-intervention and post-intervention variances, we needed at least the correlation between the pre-intervention and
post-intervention variance (Higgins 2019), which was not reported. Furthermore, as we only included randomised trials and no significant
diMerence in walking distance between the intervention and control group in each trial existed at baseline, we did not have any indication
that our main outcome, the mean diMerence in post-intervention walking distance between the intervention and control group might be
biased. We changed the P value that was considered statistically significant in case of heterogeneity from 0.05 in our protocol to 0.10 in our
full review. In the Background, we adjusted the description of the systematic review by Parmenter and colleagues (Parmenter 2011) aJer
they contacted us and added why no meta-analysis was performed in this systematic review.
I N D E X   T E R M S
Medical Subject Headings (MeSH)
Cardiovascular Diseases  [therapy];  *Exercise Test;  Exercise Therapy  [*methods];  Intermittent Claudication  [*therapy];  Randomized
Controlled Trials as Topic;  *Resistance Training;  *Walking
MeSH check words
Adult; Humans
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